false Q1 2021 0001228454 P10Y 0001228454 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001228454 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0001228454 us-gaap:DebtInstrumentRedemptionPeriodOneMember bcbp:FixedToFloatingRateSubordinatedDebenturesMember 2021-01-01 2021-03-31 0001228454 us-gaap:TreasuryStockMember 2021-03-31 0001228454 us-gaap:RetainedEarningsMember 2021-03-31 0001228454 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001228454 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001228454 us-gaap:TreasuryStockMember 2020-12-31 0001228454 us-gaap:RetainedEarningsMember 2020-12-31 0001228454 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001228454 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001228454 us-gaap:TreasuryStockMember 2020-03-31 0001228454 us-gaap:RetainedEarningsMember 2020-03-31 0001228454 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001228454 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001228454 us-gaap:TreasuryStockMember 2019-12-31 0001228454 us-gaap:RetainedEarningsMember 2019-12-31 0001228454 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001228454 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001228454 us-gaap:TrustPreferredSecuritiesSubjectToMandatoryRedemptionMember 2021-03-31 0001228454 2019-01-01 2019-12-31 0001228454 bcbp:StockPlan2011Member 2021-03-31 0001228454 bcbp:EquityIncentivePlan2018Member 2021-03-31 0001228454 srt:DirectorMember us-gaap:RestrictedStockMember bcbp:EquityIncentivePlan2018Member 2021-02-19 2021-02-19 0001228454 srt:DirectorMember us-gaap:RestrictedStockMember bcbp:EquityIncentivePlan2018Member 2021-02-10 2021-02-10 0001228454 srt:DirectorMember us-gaap:EmployeeStockOptionMember bcbp:EquityIncentivePlan2018Member 2021-02-10 2021-02-10 0001228454 us-gaap:UnallocatedFinancingReceivablesMember 2021-01-01 2021-03-31 0001228454 us-gaap:UnallocatedFinancingReceivablesMember 2020-01-01 2020-03-31 0001228454 us-gaap:ConsumerPortfolioSegmentMember 2020-01-01 2020-03-31 0001228454 us-gaap:ConstructionLoansMember 2020-01-01 2020-03-31 0001228454 us-gaap:SeriesFPreferredStockMember 2020-08-31 0001228454 us-gaap:SeriesCPreferredStockMember 2020-08-10 0001228454 us-gaap:SeriesHPreferredStockMember 2021-03-31 0001228454 us-gaap:SeriesGPreferredStockMember 2021-03-31 0001228454 us-gaap:SeriesDPreferredStockMember 2021-03-31 0001228454 us-gaap:SeriesHPreferredStockMember 2020-12-31 0001228454 us-gaap:SeriesGPreferredStockMember 2020-12-31 0001228454 us-gaap:SeriesDPreferredStockMember 2020-12-31 0001228454 us-gaap:SeriesHPreferredStockMember 2021-01-01 2021-03-31 0001228454 us-gaap:SeriesGPreferredStockMember 2021-01-01 2021-03-31 0001228454 us-gaap:SeriesDPreferredStockMember 2021-01-01 2021-03-31 0001228454 us-gaap:SeriesHPreferredStockMember 2020-12-15 2020-12-15 0001228454 us-gaap:SeriesHPreferredStockMember 2020-09-01 2020-09-01 0001228454 us-gaap:SeriesFPreferredStockMember 2020-08-31 2020-08-31 0001228454 us-gaap:SeriesCPreferredStockMember 2020-08-10 2020-08-10 0001228454 us-gaap:SeriesHPreferredStockMember 2020-07-13 2020-07-13 0001228454 us-gaap:SeriesHPreferredStockMember 2020-01-01 2020-12-31 0001228454 us-gaap:SeriesGPreferredStockMember 2020-01-01 2020-12-31 0001228454 us-gaap:SeriesDPreferredStockMember 2020-01-01 2020-12-31 0001228454 us-gaap:SeriesHPreferredStockMember 2020-01-01 2020-03-31 0001228454 us-gaap:SeriesGPreferredStockMember 2020-01-01 2020-03-31 0001228454 us-gaap:SeriesFPreferredStockMember 2020-01-01 2020-03-31 0001228454 us-gaap:SeriesDPreferredStockMember 2020-01-01 2020-03-31 0001228454 us-gaap:SeriesCPreferredStockMember 2020-01-01 2020-03-31 0001228454 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001228454 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001228454 us-gaap:FairValueInputsLevel3Member 2020-12-31 0001228454 2020-01-01 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:SubstandardMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:SpecialMentionMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:PassMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:HomeEquityMember us-gaap:SubstandardMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:HomeEquityMember us-gaap:PassMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ConsumerPortfolioSegmentMember us-gaap:PassMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ConstructionLoansMember us-gaap:SubstandardMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ConstructionLoansMember us-gaap:PassMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:SubstandardMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:SpecialMentionMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:PassMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SpecialMentionMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:PassMember 2021-03-31 0001228454 us-gaap:SubstandardMember 2021-03-31 0001228454 us-gaap:SpecialMentionMember 2021-03-31 0001228454 us-gaap:PassMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:SubstandardMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:SpecialMentionMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:PassMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:HomeEquityMember us-gaap:SubstandardMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:HomeEquityMember us-gaap:PassMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ConsumerPortfolioSegmentMember us-gaap:PassMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ConstructionLoansMember us-gaap:PassMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:SubstandardMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:SpecialMentionMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:PassMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SpecialMentionMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:PassMember 2020-12-31 0001228454 us-gaap:SubstandardMember 2020-12-31 0001228454 us-gaap:SpecialMentionMember 2020-12-31 0001228454 us-gaap:PassMember 2020-12-31 0001228454 2021-01-01 2021-01-31 0001228454 2020-08-01 2020-08-31 0001228454 us-gaap:ConstructionLoansMember 2021-01-01 2021-03-31 0001228454 us-gaap:CommercialRealEstatePortfolioSegmentMember 2021-01-01 2021-03-31 0001228454 us-gaap:CommercialPortfolioSegmentMember 2021-01-01 2021-03-31 0001228454 us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-01-01 2020-03-31 0001228454 bcbp:ImpairedLoansMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001228454 bcbp:ImpairedLoansMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0001228454 us-gaap:CoreDepositsMember 2021-03-31 0001228454 us-gaap:CoreDepositsMember 2020-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:HomeEquityMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:HomeEquityMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:HomeEquityMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ConstructionLoansMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2021-03-31 0001228454 us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2021-03-31 0001228454 us-gaap:FinancingReceivables60To89DaysPastDueMember 2021-03-31 0001228454 us-gaap:FinancingReceivables30To59DaysPastDueMember 2021-03-31 0001228454 bcbp:FinancingReceivablesLessThan90DaysPastDueMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:HomeEquityMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:HomeEquityMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:HomeEquityMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2020-12-31 0001228454 us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2020-12-31 0001228454 us-gaap:FinancingReceivables60To89DaysPastDueMember 2020-12-31 0001228454 us-gaap:FinancingReceivables30To59DaysPastDueMember 2020-12-31 0001228454 bcbp:FinancingReceivablesLessThan90DaysPastDueMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ResidentialPortfolioSegmentMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:HomeEquityMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ConsumerPortfolioSegmentMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ConstructionLoansMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialPortfolioSegmentMember 2021-03-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ResidentialPortfolioSegmentMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:HomeEquityMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ConsumerPortfolioSegmentMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:ConstructionLoansMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-12-31 0001228454 bcbp:OriginatedLoansMember us-gaap:CommercialPortfolioSegmentMember 2020-12-31 0001228454 us-gaap:PerformingFinancingReceivableMember 2021-03-31 0001228454 us-gaap:NonperformingFinancingReceivableMember 2021-03-31 0001228454 us-gaap:PerformingFinancingReceivableMember 2020-12-31 0001228454 us-gaap:NonperformingFinancingReceivableMember 2020-12-31 0001228454 us-gaap:ConsumerPortfolioSegmentMember 2021-03-31 0001228454 us-gaap:ConsumerPortfolioSegmentMember 2020-12-31 0001228454 us-gaap:ResidentialPortfolioSegmentMember 2020-01-01 2020-03-31 0001228454 us-gaap:ResidentialPortfolioSegmentMember 2021-01-01 2021-03-31 0001228454 us-gaap:HomeEquityMember 2021-01-01 2021-03-31 0001228454 us-gaap:HomeEquityMember 2020-01-01 2020-03-31 0001228454 us-gaap:CommercialPortfolioSegmentMember 2020-01-01 2020-03-31 0001228454 us-gaap:UnallocatedFinancingReceivablesMember 2021-03-31 0001228454 us-gaap:ResidentialPortfolioSegmentMember 2021-03-31 0001228454 us-gaap:HomeEquityMember 2021-03-31 0001228454 us-gaap:ConstructionLoansMember 2021-03-31 0001228454 us-gaap:CommercialRealEstatePortfolioSegmentMember 2021-03-31 0001228454 us-gaap:CommercialPortfolioSegmentMember 2021-03-31 0001228454 us-gaap:UnallocatedFinancingReceivablesMember 2020-12-31 0001228454 us-gaap:ResidentialPortfolioSegmentMember 2020-12-31 0001228454 us-gaap:HomeEquityMember 2020-12-31 0001228454 us-gaap:ConstructionLoansMember 2020-12-31 0001228454 us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-12-31 0001228454 us-gaap:CommercialPortfolioSegmentMember 2020-12-31 0001228454 us-gaap:UnallocatedFinancingReceivablesMember 2020-03-31 0001228454 us-gaap:ResidentialPortfolioSegmentMember 2020-03-31 0001228454 us-gaap:HomeEquityMember 2020-03-31 0001228454 us-gaap:ConsumerPortfolioSegmentMember 2020-03-31 0001228454 us-gaap:ConstructionLoansMember 2020-03-31 0001228454 us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0001228454 us-gaap:CommercialPortfolioSegmentMember 2020-03-31 0001228454 us-gaap:UnallocatedFinancingReceivablesMember 2019-12-31 0001228454 us-gaap:ResidentialPortfolioSegmentMember 2019-12-31 0001228454 us-gaap:HomeEquityMember 2019-12-31 0001228454 us-gaap:ConstructionLoansMember 2019-12-31 0001228454 us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0001228454 us-gaap:CommercialPortfolioSegmentMember 2019-12-31 0001228454 us-gaap:RestrictedStockMember 2021-03-31 0001228454 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0001228454 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0001228454 bcbp:FixedToFloatingRateSubordinatedDebenturesMember 2021-03-31 0001228454 bcbp:FixedToFloatingRateSubordinatedDebenturesMember 2020-12-31 0001228454 bcbp:FixedToFloatingRateSubordinatedDebenturesMember 2018-07-30 0001228454 us-gaap:DebtInstrumentRedemptionPeriodTwoMember bcbp:FixedToFloatingRateSubordinatedDebenturesMember 2021-01-01 2021-03-31 0001228454 us-gaap:TrustPreferredSecuritiesSubjectToMandatoryRedemptionMember 2021-01-01 2021-03-31 0001228454 us-gaap:SubsequentEventMember 2021-04-14 2021-04-14 0001228454 2020-03-31 0001228454 2019-12-31 0001228454 us-gaap:FairValueInputsLevel1Member 2021-03-31 0001228454 us-gaap:FairValueInputsLevel1Member 2020-12-31 0001228454 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001228454 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001228454 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001228454 us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001228454 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001228454 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001228454 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001228454 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001228454 us-gaap:CoreDepositsMember 2021-01-01 2021-03-31 0001228454 us-gaap:CoreDepositsMember 2020-01-01 2020-03-31 0001228454 2021-05-03 0001228454 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001228454 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001228454 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001228454 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001228454 us-gaap:FairValueInputsLevel3Member 2021-03-31 0001228454 srt:MinimumMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001228454 srt:MaximumMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001228454 srt:MinimumMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0001228454 srt:MaximumMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0001228454 srt:MinimumMember 2021-01-01 2021-03-31 0001228454 srt:MaximumMember 2021-01-01 2021-03-31 0001228454 2021-03-31 0001228454 2020-12-31 0001228454 us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember 2021-03-31 0001228454 us-gaap:FairValueInputsLevel2Member 2021-03-31 0001228454 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-03-31 0001228454 us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember 2020-12-31 0001228454 us-gaap:FairValueInputsLevel2Member 2020-12-31 0001228454 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-12-31 0001228454 bcbp:FixedToFloatingRateSubordinatedDebenturesMember 2021-01-01 2021-03-31 0001228454 us-gaap:CorporateDebtSecuritiesMember 2021-03-31 0001228454 us-gaap:CorporateDebtSecuritiesMember 2020-12-31 0001228454 us-gaap:USStatesAndPoliticalSubdivisionsMember 2021-03-31 0001228454 us-gaap:ResidentialMortgageBackedSecuritiesMember 2021-03-31 0001228454 us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-12-31 0001228454 us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-12-31 0001228454 2021-01-01 2021-03-31 0001228454 2020-01-01 2020-03-31 bcbp:loan xbrli:pure xbrli:shares iso4217:USD xbrli:shares bcbp:item iso4217:USD

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

Or

o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission File Number: 0-50275

BCB Bancorp, Inc.

(Exact name of registrant as specified in its charter)

New Jersey |  | 26-0065262
(State or other jurisdiction of incorporation or organization) |  | (IRS Employer I.D. No.)
104-110 Avenue C Bayonne, New Jersey |  | 07002
(Address of principal executive offices) |  | (Zip Code)

(201) 823-0700

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year if changed since last report)

Securities registered pursuant to section 12(b) of the Securities and Exchange Act of 1934:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, no par value | BCBP | The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. T Yes o No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). x Yes o No

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer | o |  | Accelerated Filer | x
Non-Accelerated Filer | o |  | Smaller Reporting Company | x
|  |  | Emerging Growth Company | o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act). o Yes T No

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of May 3, 2021, BCB Bancorp, Inc., had 17,121,319 shares of common stock, no par value, outstanding.

‎

BCB BANCORP INC. AND SUBSIDIARIES

INDEX

|  | Page |
PART I. CONSOLIDATED FINANCIAL INFORMATION |  |  |  |
Item 1. Consolidated Financial Statements |  |  |  |
Consolidated Statements of Financial Condition as of March 31, 2021 (unaudited) and December 31, 2020 (unaudited) |  |  | 1 |
Consolidated Statements of Income for the three months ended March 31, 2021 and 2020 (unaudited) |  |  | 2 |
Consolidated Statements of Comprehensive Income for the three months ended March 31, 2021 and 2020 (unaudited) |  |  | 3 |
Consolidated Statement of Changes in Stockholders’ Equity for the three months ended March 31, 2021 and 2020 (unaudited) |  |  | 4 |
Consolidated Statements of Cash Flows for the three months ended March 31, 2021 and 2020 (unaudited) |  |  | 5 |
Notes to Unaudited Consolidated Financial Statements |  |  | 6 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |  |  | 23 |
Item 3. Quantitative and Qualitative Disclosures about Market Risk |  |  | 30 |
Item 4. Controls and Procedures |  |  | 30 |
PART II. OTHER INFORMATION |  |  | 30 |
Item 1. Legal Proceedings |  |  | 30 |
Item 1A. Risk Factors |  |  | 31 |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |  |  | 31 |
Item 3. Defaults Upon Senior Securities |  |  | 31 |
Item 4. Mine Safety Disclosures |  |  | 31 |
Item 5. Other Information |  |  | 31 |
Item 6. Exhibits |  |  | 32 |

PART I. CONSOLIDATED FINANCIAL INFORMATION

ITEM I. CONSOLIDATED FINANCIAL STATEMENTS

BCB BANCORP INC. AND SUBSIDIARIES

Consolidated Statements of Financial Condition

(In thousands, Except Share and Per Share Data, Unaudited)

| March 31, |  | December 31,
| 2021 |  | 2020
ASSETS |  |  |  |  |
Cash and amounts due from depository institutions | $ | 24,796 |  | $ | 23,201
Interest-earning deposits |  | 272,142 |  |  | 238,028
Total cash and cash equivalents |  | 296,938 |  |  | 261,229
Interest-earning time deposits |  | 735 |  |  | 735
Debt securities available for sale |  | 93,582 |  |  | 99,756
Equity investments |  | 18,278 |  |  | 17,717
Loans held for sale |  | 1,147 |  |  | 3,530
Loans receivable, net of allowance for loan losses |  |  |  |  |
of $35,477 and $33,639 respectively |  | 2,296,434 |  |  | 2,295,021
Federal Home Loan Bank of New York stock, at cost |  | 8,920 |  |  | 11,324
Premises and equipment, net |  | 14,796 |  |  | 15,272
Accrued interest receivable |  | 12,056 |  |  | 12,924
Other real estate owned |  | 414 |  |  | 414
Deferred income taxes |  | 13,239 |  |  | 12,574
Goodwill and other intangibles |  | 5,472 |  |  | 5,488
Operating lease right-of-use assets |  | 14,328 |  |  | 14,988
Bank-owned life insurance ("BOLI") |  | 70,234 |  |  | 61,033
Other assets |  | 5,887 |  |  | 9,011
Total Assets | $ | 2,852,460 |  | $ | 2,821,016
LIABILITIES AND STOCKHOLDERS' EQUITY |  |  |  |  |
LIABILITIES |  |  |  |  |
Non-interest -bearing deposits | $ | 454,061 |  | $ | 402,100
Interest bearing deposits |  | 1,950,074 |  |  | 1,915,950
Total deposits |  | 2,404,135 |  |  | 2,318,050
FHLB advances |  | 133,298 |  |  | 191,161
Subordinated debentures |  | 37,101 |  |  | 37,042
Operating lease liability |  | 14,589 |  |  | 15,224
Other liabilities |  | 9,883 |  |  | 10,328
Total Liabilities |  | 2,599,006 |  |  | 2,571,805
STOCKHOLDERS' EQUITY |  |  |  |  |
Preferred stock: $0.01 par value, 10,000,000 shares authorized; issued and outstanding 2,596 shares of Series D 4.5%, Series G 6%, and Series H 3.5%, (liquidation value $10,000 per share) noncumulative perpetual preferred stock at March 31, 2021 and December 31, 2020 |  | - |  |  | -
Additional paid-in capital preferred stock |  | 25,723 |  |  | 25,723
Common stock: no par value; 40,000,000 shares authorized; issued 19,620,630 and 19,574,858 at March 31, 2021 and December 31, 2020, respectively, outstanding 17,121,319 shares and 17,107,640 shares, at March 31, 2021 and December 31, 2020, respectively |  | - |  |  | -
Additional paid-in capital common stock |  | 192,633 |  |  | 192,276
Retained earnings |  | 62,777 |  |  | 58,335
Accumulated other comprehensive loss |  | (349) |  |  | (205)
Treasury stock, at cost, 2,499,311 and 2,467,218 shares at March 31, 2021 and December 31, 2020, respectively |  | (27,330) |  |  | (26,918)
Total Stockholders' Equity |  | 253,454 |  |  | 249,211
Total Liabilities and Stockholders' Equity | $ | 2,852,460 |  | $ | 2,821,016
See accompanying notes to unaudited consolidated financial statements. |  |  |  |  |

‎

1

BCB BANCORP INC. AND SUBSIDIARIES

Consolidated Statements of Income

(In thousands, Except for Per Share Amounts, Unaudited)

| Three Months Ended March 31, |
| 2021 |  | 2020 |
Interest and dividend income: |  |  |  |  |  |
Loans, including fees | $ | 26,863 |  | $ | 26,814 |
Mortgage-backed securities |  | 206 |  |  | 563 |
Other investment securities |  | 784 |  |  | 8 |
FHLB stock and other interest earning assets |  | 222 |  |  | 2,034 |
Total interest income |  | 28,075 |  |  | 29,419 |
Interest expense: |  |  |  |  |  |
Deposits: |  |  |  |  |  |
Demand |  | 1,198 |  |  | 2,208 |
Savings and club |  | 118 |  |  | 105 |
Certificates of deposit |  | 1,992 |  |  | 6,432 |
|  | 3,308 |  |  | 8,745 |
Borrowings |  | 1,205 |  |  | 1,896 |
Total interest expense |  | 4,513 |  |  | 10,641 |
Net interest income |  | 23,562 |  |  | 18,778 |
Provision for loan losses |  | 1,865 |  |  | 1,500 |
Net interest income after provision for loan losses |  | 21,697 |  |  | 17,278 |
Non-interest income: |  |  |  |  |  |
Fees and service charges |  | 1,111 |  |  | 726 |
Bank-owned Life Insurance ("BOLI") income |  | 701 |  |  | - |
Gain on sales of loans |  | 274 |  |  | 61 |
Realized and unrealized loss on equity investments |  | (196) |  |  | (440) |
Other |  | 60 |  |  | 336 |
Total non-interest income |  | 1,950 |  |  | 683 |
Non-interest expense: |  |  |  |  |  |
Salaries and employee benefits |  | 6,545 |  |  | 7,389 |
Occupancy and equipment |  | 2,953 |  |  | 2,824 |
Data processing and service fees |  | 1,008 |  |  | 938 |
Professional fees |  | 412 |  |  | 470 |
Director fees |  | 247 |  |  | 358 |
Regulatory assessments |  | 376 |  |  | 321 |
Advertising and promotional |  | 12 |  |  | 61 |
Other real estate owned, net |  | 4 |  |  | 26 |
Loss from extinguishment of debt |  | 540 |  |  | - |
Other |  | 1,486 |  |  | 1,977 |
Total non-interest expense |  | 13,583 |  |  | 14,364 |
Income before income tax provision |  | 10,064 |  |  | 3,597 |
Income tax provision |  | 2,947 |  |  | 1,076 |
Net Income | $ | 7,117 |  | $ | 2,521 |
Preferred stock dividends |  | 283 |  |  | 342 |
Net Income available to common stockholders | $ | 6,834 |  | $ | 2,179 |
Net Income per common share-basic and diluted |  |  |  |  |  |
Basic | $ | 0.40 |  | $ | 0.12 |
Diluted | $ | 0.40 |  | $ | 0.12 |
Weighted average number of common shares outstanding |  |  |  |  |  |
Basic |  | 17,115 |  |  | 17,502 |
Diluted |  | 17,232 |  |  | 17,551 |

See accompanying notes to unaudited consolidated financial statements.

2

BCB BANCORP INC. AND SUBSIDIARIES

Consolidated Statements of Comprehensive Income

(In thousands, Unaudited)

| Three Months Ended March 31, |
| 2021 |  | 2020 |
Net Income | $ | 7,117 |  | $ | 2,521 |
Other comprehensive (loss) income, net of tax: |  |  |  |  |  |
Unrealized (losses) gains on available-for-sale debt securities: |  |  |  |  |  |
Unrealized holding (losses) gains arising during the period |  | (192) |  |  | 3,309 |
Tax Effect |  | 48 |  |  | (820) |
Other comprehensive (loss) income |  | (144) |  |  | 2,489 |
Comprehensive income | $ | 6,973 |  | $ | 5,010 |

See accompanying notes to unaudited consolidated financial statements.

3

BCB BANCORP INC. AND SUBSIDIARIES

Consolidated Statement of Changes in Stockholders’ Equity

(In thousands, Except Share and Per Share Data, Unaudited)

| Preferred ‎Stock |  | Common ‎Stock |  | Additional ‎Paid-In ‎Capital |  | Retained ‎Earnings |  | Treasury ‎Stock |  | Accumulated ‎Other ‎Comprehensive ‎Income ‎(Loss) |  | Total
Balance at January 1, 2021 | $ | - |  | $ | - |  | $ | 217,999 |  | $ | 58,335 |  | $ | (26,918) |  | $ | (205) |  | $ | 249,211
Net income |  | - |  |  | - |  |  | - |  |  | 7,117 |  |  | - |  |  | - |  |  | 7,117
Other comprehensive loss |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | (144) |  |  | (144)
Stock-based compensation expense |  | - |  |  | - |  |  | 135 |  |  | - |  |  | - |  |  | - |  |  | 135
Treasury stock purchases (32,093 shares) |  | - |  |  | - |  |  | - |  |  | - |  |  | (412) |  |  | - |  |  | (412)
Dividends payable on Series D 4.5%, Series G 6%, and Series H 3.5% noncumulative perpetual preferred stock |  | - |  |  | - |  |  | - |  |  | (283) |  |  | - |  |  | - |  |  | (283)
Cash dividends on common stock ($0.14 per share declared) |  | - |  |  | - |  |  | - |  |  | (2,281) |  |  | - |  |  | - |  |  | (2,281)
Dividend reinvestment plan |  | - |  |  | - |  |  | 111 |  |  | (111) |  |  | - |  |  | - |  |  | -
Stock purchase plan |  | - |  |  | - |  |  | 111 |  |  | - |  |  | - |  |  | - |  |  | 111
Balance at March 31, 2021 | $ | - |  | $ | - |  | $ | 218,356 |  | $ | 62,777 |  | $ | (27,330) |  | $ | (349) |  | $ | 253,454
| Preferred ‎Stock |  | Common ‎Stock |  | Additional ‎Paid-In ‎Capital |  | Retained ‎Earnings |  | Treasury ‎Stock |  | Accumulated ‎Other ‎Comprehensive ‎Income (Loss) |  | Total
Balance at January 1, 2020 | $ | - |  | $ | - |  | $ | 215,310 |  | $ | 48,429 |  | $ | (22,048) |  | $ | (2,218) |  | $ | 239,473
Net income |  | - |  |  | - |  |  | - |  |  | 2,521 |  |  | - |  |  | - |  |  | 2,521
Other comprehensive income |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 2,489 |  |  | 2,489
Cost for Issuance of common stock |  | - |  |  | - |  |  | (126) |  |  | - |  |  | - |  |  | - |  |  | (126)
Redemption of Series D Preferred Stock |  | - |  |  | - |  |  | (140) |  |  | - |  |  | - |  |  | - |  |  | (140)
Exercise Stock Option Expense (500 shares) |  | - |  |  | - |  |  | 5 |  |  | - |  |  | - |  |  | - |  |  | 5
Stock-based compensation expense |  | - |  |  | - |  |  | 279 |  |  | - |  |  | - |  |  | - |  |  | 279
Treasury stock purchases (127,058 shares) |  | - |  |  | - |  |  | - |  |  | - |  |  | (1,287) |  |  | - |  |  | (1,287)
Dividends payable on Series C 6%, Series D 4.5%, Series F 6%, Series G 6%, and Series H 3.5% noncumulative perpetual preferred stock |  | - |  |  | - |  |  | - |  |  | (342) |  |  | - |  |  | - |  |  | (342)
Cash dividends on common stock ($0.14 per share declared) |  | - |  |  | - |  |  | - |  |  | (2,336) |  |  | - |  |  | - |  |  | (2,336)
Dividend reinvestment plan |  | - |  |  | - |  |  | 104 |  |  | (104) |  |  | - |  |  | - |  |  | -
Stock purchase plan |  | - |  |  | - |  |  | 102 |  |  | - |  |  | - |  |  | - |  |  | 102
Balance at March 31, 2020 | $ | - |  | $ | - |  | $ | 215,534 |  | $ | 48,168 |  | $ | (23,335) |  | $ | 271 |  | $ | 240,638

See accompanying notes to unaudited consolidated financial statements.
‎

4

BCB BANCORP INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(In thousands, Unaudited)

| Three Months Ended March 31,
| 2021 |  | 2020
Cash Flows from Operating Activities : |  |  |  |  |
Net Income | $ | 7,117 |  | $ | 2,521
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |  |  |
Depreciation of premises and equipment |  | 634 |  |  | 734
Amortization and accretion, net |  | (191) |  |  | (579)
Provision for loan losses |  | 1,865 |  |  | 1,500
Deferred income tax benefit |  | (617) |  |  | (293)
Loans originated for sale |  | (10,074) |  |  | (3,868)
Proceeds from sales of loans |  | 12,731 |  |  | 4,008
Gain on sales of loans originated for sale |  | (274) |  |  | (61)
Realized and unrealized loss on equity investments |  | 196 |  |  | 440
Stock-based compensation expense |  | 135 |  |  | 279
BOLI income |  | (701) |  |  | -
Decrease (increase) in interest receivable |  | 868 |  |  | (618)
Decrease (increase) in other assets |  | 3,124 |  |  | (186)
Decrease in accrued interest payable |  | (656) |  |  | (516)
Increase in other liabilities |  | 211 |  |  | 2,304
Net Cash Provided by Operating Activities |  | 14,368 |  |  | 5,665
Cash flows from investing activities: |  |  |  |  |
Proceeds from repayments, calls, and maturities on securities available for sale |  | 5,843 |  |  | 7,413
Purchases of securities |  | (757) |  |  | (7,502)
Proceeds from bulk sale of impaired loans |  | 180 |  |  | -
Net (increase) decrease in loans receivable |  | (2,891) |  |  | 13,594
Purchases of BOLI |  | (8,500) |  |  | -
Additions to premises and equipment |  | (158) |  |  | (106)
Redemption (Purchase) of Federal Home Loan Bank of New York stock |  | 2,404 |  |  | (765)
Net Cash (Used In) Provided by Investing Activities |  | (3,879) |  |  | 12,634
Cash flows from financing activities: |  |  |  |  |
Net increase in deposits |  | 86,085 |  |  | 13,658
Proceeds from Federal Home Loan Bank of New York advances |  | 10,000 |  |  | 27,000
Repayments of Federal Home Loan Bank of New York advances |  | (68,000) |  |  | (10,000)
Purchases of treasury stock |  | (412) |  |  | (1,287)
Cash dividends paid on common stock |  | (2,281) |  |  | (2,336)
Cash dividends paid on preferred stock |  | (283) |  |  | (342)
Net proceeds (costs) from issuance of common stock |  | 111 |  |  | (24)
Net payment on redemption of preferred stock |  | - |  |  | (140)
Exercise of stock options |  | - |  |  | 5
Net Cash Provided by Financing Activities |  | 25,220 |  |  | 26,534
Net Increase in Cash and Cash Equivalents |  | 35,709 |  |  | 44,833
Cash and Cash Equivalents-Beginning |  | 261,229 |  |  | 550,353
Cash and Cash Equivalents-Ending | $ | 296,938 |  | $ | 595,186
Supplementary Cash Flow Information: |  |  |  |  |
Cash paid during the year for: |  |  |  |  |
Income taxes | $ | 375 |  | $ | 279
Interest |  | 5,169 |  |  | 11,157

See accompanying notes to unaudited consolidated financial statements

‎

5

BCB Bancorp Inc. and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

Note 1 – Basis of Presentation

The accompanying unaudited consolidated financial statements include the accounts of BCB Bancorp, Inc. (the “Company”) and the Company’s wholly owned subsidiaries, BCB Community Bank (the “Bank”), BCB Holding Company Investment Corporation, Special Asset REO I, LLC., and Special Asset REO II, LLC. The Company’s business is conducted principally through the Bank. All significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Regulation S-X and, therefore, do not necessarily include all information that would be included in audited consolidated financial statements. The information furnished reflects all adjustments that are, in the opinion of management, necessary for a fair presentation of consolidated financial condition and results of operations. All such adjustments are of a normal recurring nature. These results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, or any other future period. The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated statement of financial condition and revenues and expenses for the periods then ended. Actual results could differ significantly from those estimates.

These unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the year ended December 31, 2020, which are included in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission. In preparing these consolidated financial statements, the Company evaluated the events and transactions that occurred between December 31, 2020 and the date these consolidated financial statements were issued.

Risks and Uncertainties - We are subject to risks and uncertainties as a result of the ongoing COVID-19 pandemic. The extent of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict.

The severity of the impact of the ongoing COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company's customers and any government or governmental responses thereto, including legislative or regulatory changes as well as the distribution and effectiveness of COVID-19 vaccines, all of which are uncertain and cannot be predicted. The Company's future results of operations and liquidity could be adversely impacted. As of the date of issuance of these condensed consolidated financial statements, the extent to which the COVID-19 pandemic may materially impact the Company's financial condition, liquidity, or results of operations is uncertain.

Note 2 - Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses ASU 2016-13, and related guidance, requires entities to report “expected” credit losses on financial instruments and other commitments to extend credit rather than the current “incurred loss” model. These expected credit losses for financial assets held at the reporting date are to be based on historical experience, current conditions, and reasonable and supportable forecasts. This ASU will also require enhanced disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. These disclosures include qualitative and quantitative requirements that provide additional information about the amounts recorded in the consolidated financial statements. The amendments are effective for the Company in 2023. The Company has begun evaluating the impact the adoption of ASU 2016-13 will have on its consolidated financial statements and results of operations. The effect of this change cannot be ascertained at this point, and will depend upon factors including asset components, asset quality and market conditions at the adoption date. The Company has created a Current Expected Credit Loss (“CECL”) task group comprised of members of its finance, credit administration, lending, internal audit, loan operations, compliance, and information systems units. The CECL task group has become familiar with the provisions of ASU 2016-13 and is in the process of implementing the new guidance, which includes, but is not limited to: (1) identifying segments and sub-segments within the loan portfolio that have similar risk characteristics; (2) determining the appropriate methodology for each segment; (3) implementing changes that are necessary to its core operating system and interfaces to be able to capture appropriate data requirements; and (4) evaluating qualitative and economic factors to develop appropriate forecasts for integration into the model. The Company is currently evaluating the effect this guidance may have on its operating results and/or financial position, including assessing any potential impact on its capital.

Note 3 – Reclassification

Certain amounts as of December 31, 2020 and for the three-month period March 31, 2020 have been reclassified to conform to the current period’s presentation. These changes had no effect on the Company’s results of operations or financial position.

Note 4 – Equity Incentive Plans

Equity Incentive Plans

The Company, under the plan approved by its shareholders on April 28, 2011 (“2011 Stock Plan”), authorized the issuance of up to 900,000 shares of common stock of the Company pursuant to grants of stock options. Employees and directors of the Company and the Bank are eligible to participate in the 2011 Stock Plan. All stock options will be granted in the form of either "incentive" stock options or "non-qualified" stock options. Incentive stock options have certain tax advantages that must comply with the requirements of Section 422 of the Internal Revenue Code. Only employees are permitted to receive incentive stock options.

The Company, under the plan approved by its shareholders on April 26, 2018 (“2018 Equity Incentive Plan”), authorized the issuance of up to 1,000,000 shares of common stock of the Company pursuant to grants of stock options and restricted stock units. Employees and directors of the Company and the Bank are eligible to participate in the 2018 Stock Plan. All stock options will be granted in the form of either "incentive" stock options or "non-qualified" stock options. Incentive stock options have certain tax advantages that must comply with the requirements of Section 422 of the Internal Revenue Code. Only employees are permitted to receive incentive stock options.

On February 10, 2021, grants of 66,000 options, in aggregate, were declared for members of the Board of Directors of the Bank and the Company which vest over a 5-year period, commencing on the first anniversary of the grant date. The exercise price was recorded as of close of business on February 10, 2021. On February 10, 2021, awards of 26,400 shares of restricted stock, in aggregate, were declared for members of the Board of Directors of the Bank and the Company, which vest over a 4-year period, commencing on the anniversary of the award date. On February 19, 2021, an award of 300 shares of restricted stock was declared for an officer of the Bank and the Company, which vest over a 2-year period, commencing on the anniversary of the award date.

‎

6

Note 4 – Equity Incentive Plans (Continued)

The following table presents a summary of the status of the Company’s restricted shares as of March 31, 2021 and 2020.

| Number of Shares Awarded |  |  | Weighted Average Grant Date Fair Value
Non-vested at January 1, 2021 | 22,304 |  | $ | 12.46
Granted | 26,700 |  |  | 12.89
Vested | - |  |  | -
Forfeited | - |  |  | -
Non-vested at March 31, 2021 | 49,004 |  | $ | 12.70

| Number of Shares Awarded |  |  | Weighted Average Grant Date Fair Value
Non-vested at January 1, 2020 | 81,278 |  | $ | 11.96
Granted | - |  |  | -
Vested | - |  |  | -
Forfeited | - |  |  | -
Non-vested at March 31, 2020 | 81,278 |  | $ | 11.96

Expected future expenses relating to the non-vested restricted shares outstanding as of March 31, 2021 was approximately $361,000 over a weighted average period of 3.28 years.

The following tables present a summary of the status of the Company’s outstanding stock option awards as of March 31, 2021 and 2020.

|  | Number of Option Shares |  |  | Range of Exercise Prices |  |  | Weighted Average Exercise Price
Outstanding at January 1, 2021 |  | 1,192,348 |  | $ | 8.93 - 13.32 |  | $ | 11.45
Options granted |  | 66,000 |  |  | 12.93 |  |  | 12.93
Options exercised |  | (7,000) |  |  | 9.39 |  |  | 9.39
Options forfeited |  | - |  |  | - |  |  | -
Options expired |  | - |  |  | - |  |  | -
Outstanding at March 31, 2021 |  | 1,251,348 |  | $ | 8.93 - 13.32 |  | $ | 11.54

As of March 31, 2021, stock options which were granted and were exercisable totaled 824,536 stock options.

It is Company policy to issue new shares upon share option exercise. Expected future compensation expense relating to the 426,812 shares of unvested options outstanding as of March 31, 2021 was $713,000 over a weighted average period of 4.99 years.

|  | Number of Option Shares |  |  | Range of Exercise Prices |  |  | Weighted Average Exercise Price
Outstanding at January 1, 2020 |  | 1,200,975 |  | $ | 8.93-13.32 |  | $ | 11.45
Options granted |  | - |  |  | - |  |  | -
Options exercised |  | (500) |  |  | 10.55 |  |  | 10.55
Options forfeited |  | - |  |  | - |  |  | -
Options expired |  | - |  |  | - |  |  | -
Outstanding at March 31, 2020 |  | 1,200,475 |  | $ | 8.93-13.32 |  | $ | 11.45

As of March 31, 2020, stock options which were granted and were exercisable totaled 515,800 stock options.

‎

7

Note 5 – Net Income per Common Share

Basic net income per common share is computed by dividing net income less dividends on preferred stock by the weighted average number of shares of common stock outstanding. The diluted net income per common share is computed by adjusting the weighted average number of shares of common stock outstanding to include the effects of outstanding stock options, if dilutive, using the treasury stock method. Dilution is not applicable in periods of net loss. For the three months ended March 31, 2021 and 2020, the difference in the weighted average number of basic and diluted common shares was due solely to the effects of outstanding stock options. No adjustments to net income were necessary in calculating basic and diluted net income per share. For the three months ended March 31, 2021 and 2020, the weighted average number of outstanding options considered to be anti-dilutive were 0 and 687, respectively.

The following is a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations:

|  | For the Three Months Ended March 31,
|  | 2021 |  | 2020
|  |  | Income |  | Shares |  |  | Per Share |  |  | Income |  | Shares |  |  | Per Share
|  |  | (Numerator) |  | (Denominator) |  |  | Amount |  |  | (Numerator) |  | (Denominator) |  |  | Amount
|  | (In Thousands, except per share data)
Net income available to common stockholders |  | $ | 6,834 |  |  |  |  |  |  | $ | 2,179 |  |  |  |  |
Basic earnings per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income available to common stockholders |  | $ | 6,834 |  | 17,115 |  | $ | 0.40 |  | $ | 2,179 |  | 17,502 |  | $ | 0.12
Effect of dilutive securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options |  |  | - |  | 117 |  |  |  |  |  | - |  | 49 |  |  |
Diluted earnings per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income available to common stockholders |  | $ | 6,834 |  | 17,232 |  | $ | 0.40 |  | $ | 2,179 |  | 17,551 |  | $ | 0.12

Note 6 - Securities

Equity Securities

Equity securities are defined to include (a) preferred, common and other ownership interests in entities including partnerships, joint ventures and limited liability companies and (b) rights to acquire or dispose of ownership interest in entities at fixed or determinable prices.

The following is a summary of unrealized and realized gains and losses recognized in net income on equity securities during the three-months ended March 31, 2021 and 2020:

|  | For the three months ended March 31, |
(In Thousands) |  | 2021 |  | 2020 |
Net losses recognized during the period on equity securities |  | $ | (196) |  | $ | (440) |
Less: Net gains recognized during the period on equity securities sold during the period |  |  | - |  |  | - |
Unrealized losses recognized during the reporting period on equity securities still held at the reporting date |  | $ | (196) |  | $ | (440) |

Debt Securities Available for Sale

The following tables present by maturity the amortized cost, gross unrealized gains and losses on, and fair value of, securities available for sale as of March 31, 2021 and December 31, 2020:

| March 31, 2021
|  |  |  | Gross |  | Gross |  |
| Amortized |  | Unrealized |  | Unrealized |  |  |
| Cost |  | Gains |  | Losses |  | Fair Value
| (In Thousands)
Residential Mortgage-backed securities: |  |  |  |  |  |  |  |  |  |  |
More than one to five years | $ | 3,157 |  | $ | 2 |  | $ | 72 |  | $ | 3,087
More than five to ten years |  | 4,429 |  |  | 139 |  |  | 22 |  |  | 4,546
More than ten years |  | 34,995 |  |  | 622 |  |  | 398 |  |  | 35,219
|  | 42,581 |  |  | 763 |  |  | 492 |  |  | 42,852
Corporate Debt securities: |  |  |  |  |  |  |  |  |  |  |
More than five to ten years |  | 32,280 |  |  | 2,077 |  |  | 25 |  |  | 34,332
Municipal obligations: |  |  |  |  |  |  |  |  |  |  |
Less than one year |  | 12,048 |  |  | - |  |  | - |  |  | 12,048
More than ten years |  | 4,183 |  |  | 167 |  |  | - |  |  | 4,350
|  | 16,231 |  |  | 167 |  |  | - |  |  | 16,398
Total securities | $ | 91,092 |  | $ | 3,007 |  | $ | 517 |  | $ | 93,582

‎

8

| December 31, 2020
|  |  |  | Gross |  | Gross |  |
| Amortized |  | Unrealized |  | Unrealized |  |  |
| Cost |  | Gains |  | Losses |  | Fair Value
| (In Thousands)
Residential Mortgage-backed securities: |  |  |  |  |  |  |  |  |  |  |
More than one to five years | $ | 3,208 |  | $ | 10 |  | $ | 67 |  | $ | 3,151
More than five to ten years |  | 4,799 |  |  | 163 |  |  | - |  |  | 4,962
More than ten years |  | 40,531 |  |  | 741 |  |  | 60 |  |  | 41,212
Sub-total: |  | 48,538 |  |  | 914 |  |  | 127 |  |  | 49,325
Corporate Debt securities: |  |  |  |  |  |  |  |  |  |  |
More than five to ten years |  | 32,279 |  |  | 1,719 |  |  | 13 |  |  | 33,985
Sub-total: |  | 32,279 |  |  | 1,719 |  |  | 13 |  |  | 33,985
Municipal obligations: |  |  |  |  |  |  |  |  |  |  |
Due within one year |  | 12,048 |  |  | - |  |  | - |  |  | 12,048
Due after ten years |  | 4,209 |  |  | 189 |  |  | - |  |  | 4,398
Sub-total: |  | 16,257 |  |  | 189 |  |  | - |  |  | 16,446
Total Debt Securities Available | $ | 97,074 |  | $ | 2,822 |  | $ | 140 |  | $ | 99,756

The unrealized losses, categorized by the length of time of continuous loss position, and fair value of related securities available for sale were as follows:

| 12 Months or Less |  | More than 12 Months |  | Total
| Fair |  | Unrealized |  | Fair |  | Unrealized |  | Fair |  | Unrealized
| Value |  | Losses |  | Value |  | Losses |  | Value |  | Losses
| (In Thousands)
March 31, 2021 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Residential mortgage-backed securities | $ | 12,221 |  | $ | 420 |  | $ | 1,263 |  | $ | 72 |  | $ | 13,484 |  | $ | 492
Corporate Debt securities |  | 975 |  |  | 25 |  |  | - |  |  | - |  |  | 975 |  |  | 25
| $ | 13,196 |  | $ | 445 |  | $ | 1,263 |  | $ | 72 |  | $ | 14,459 |  | $ | 517
December 31, 2020 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Residential mortgage-backed securities | $ | 6,126 |  | $ | 60 |  | $ | 1,278 |  | $ | 67 |  | $ | 7,404 |  | $ | 127
Corporate Debt Securities |  | 5,487 |  |  | 13 |  |  | - |  |  | - |  |  | 5,487 |  |  | 13
| $ | 11,613 |  | $ | 73 |  | $ | 1,278 |  | $ | 67 |  | $ | 12,891 |  | $ | 140

Management evaluates securities for other-than-temporary impairment (“OTTI”) at least on a quarterly basis, and more frequently when economic or market conditions warrant such evaluation. Consideration is given to (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, and (3) whether the Company intends to sell the security or more likely than not will be required to sell the security before its anticipated recovery. At March 31, 2021 and December 31, 2020, management performed an assessment for possible OTTI of the Company’s residential mortgage-backed securities on an issue-by-issue basis, relying on information obtained from various sources, including publicly available financial data, ratings by external agencies, brokers and other sources. The extent of individual analysis applied to each security depended on the size of the Company’s investment, as well as management’s perception of the credit risk associated with each security. Based on the results of the assessment, management believes impairment of these securities, at March 31, 2021 and December 31, 2020, to be temporary.

Note 7 - Loans Receivable and Allowance for Loan Losses

The following tables present the recorded investment in loans receivable as of March 31, 2021 and December 31, 2020 by segment and class:

| March 31, 2021 |  | December 31, 2020
|  | (In Thousands)
Residential one-to-four family | $ | 234,375 |  | $ | 244,369
Commercial and multi-family |  | 1,700,113 |  |  | 1,690,836
Construction |  | 167,224 |  |  | 155,967
Commercial business(1) |  | 177,340 |  |  | 184,357
Home equity(2) |  | 53,360 |  |  | 53,667
Consumer |  | 851 |  |  | 822
|  | 2,333,263 |  |  | 2,330,018
Less: |  |  |  |  |
Deferred loan fees, net |  | (1,352) |  |  | (1,358)
Allowance for loan losses |  | (35,477) |  |  | (33,639)
Sub-total |  | (36,829) |  |  | (34,997)
Total Loans, net | $ | 2,296,434 |  | $ | 2,295,021
(1) Includes business lines of credit. |  |  |  |  |
(2) Includes home equity lines of credit. |  | - |  |  |

‎

9

Note 7 – Loans Receivable and Allowance for Loan Losses (Continued)

Allowance for Loan Losses

The allowance for loan loss is evaluated regularly by management and reflects consideration of all significant factors that affect the collectability of the loan portfolio. The Company’s methodology for assessing the adequacy of the allowance for loan losses consists of several key elements. These elements include a general allocated reserve for performing loans, a specific reserve for impaired loans and an unallocated portion.

The Company consistently applies the following comprehensive methodology. During the quarterly review of the allowance for loan losses, the Company considers a variety of qualitative factors that include:

Lending Policies and Procedures

Personnel responsible for the particular portfolio - relative to experience and ability of staff

Trend for past due, criticized and classified loans

Relevant economic factors

Quality of the loan review system

Value of collateral for collateral dependent loans

The effect of any concentrations of credit and the changes in the level of such concentrations

Other external factors

The methodology includes the segregation of the loan portfolio into two divisions. Loans that are performing and loans that are impaired. Loans which are performing are evaluated by loan class or loan type. The allowance for performing loans is evaluated based on historical loan loss experience with an adjustment for qualitative factors referred to above. Impaired loans are loans which are more than 90 days delinquent, troubled debt restructured, or adversely classified. These loans are individually evaluated for loan loss either by current appraisal, or net present value. Management reviews the overall estimate for feasibility and establishes the loan loss provision accordingly. Loan categories for specific business types were stressed due to rising delinquencies within those market sectors (hospitality, restaurants, office space, and commercial condos) to determine the potential for collateral shortfalls.

The loan portfolio is segmented into the following loan segments, where the risk level for each class is analyzed when determining the allowance for loan losses:

Residential one-to-four family real estate loans involve certain risks such as interest rate risk and risk of non-repayment. Adjustable-rate residential real estate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default. At the same time, the marketability of the underlying properties may be adversely affected by higher interest rates. Repayment risk may be affected by a number of factors including, but not necessarily limited to, job loss, divorce, illness and personal bankruptcy of the borrower.

Commercial and multi-family real estate lending entails additional risks as compared with residential family property lending. Such loans typically involve large loan balances to single borrowers or groups of related borrowers. The payment experience on such loans is typically dependent on the successful operation of the real estate project. The success of such projects is sensitive to changes in supply and demand conditions in the market for commercial real estate as well as economic conditions generally.

Construction lending is generally considered to involve a high risk due to the concentration of principal in a limited number of loans and borrowers and the effects of the general economic conditions on developers and builders. Moreover, a construction loan can involve additional risks because of the inherent difficulty in estimating both a property’s value at completion of the project and the estimated cost (including interest) of the project. The nature of these loans is such that they are generally difficult to evaluate and monitor. In addition, speculative construction loans to a builder are not necessarily pre-sold and thus pose a greater potential risk to the Bank than construction loans to individuals on their personal residence.

Commercial business lending, including lines of credit, is generally considered higher risk due to the concentration of principal in a limited number of loans and borrowers and the effects of general economic conditions on the business. Commercial business loans are primarily secured by inventories and other business assets. In many cases, any repossessed collateral for a defaulted commercial business loans will not provide an adequate source of repayment of the outstanding loan balance.

Home equity lending entails certain risks such as interest rate risk and risk of non-repayment. The marketability of the underlying property may be adversely affected by higher interest rates, decreasing the collateral value securing the loan. Repayment risk can be affected by job loss, divorce, illness and personal bankruptcy of the borrower. Home equity line of credit lending entails securing an equity interest in the borrower’s home. In many cases, the Bank’s position in these loans is as a junior lien holder to another institution’s superior lien. This type of lending is often priced on an adjustable rate basis with the rate set at or above a predefined index. Adjustable-rate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default.

Consumer loans generally have more credit risk because of the type and nature of the collateral and, in certain cases, the absence of collateral. Consumer loans generally have shorter terms and higher interest rates than other lending. In addition, consumer lending collections are dependent on the borrower’s continuing financial stability, and thus are more likely to be adversely affected by job loss, divorce, illness, and personal bankruptcy. In many cases, any repossessed collateral for a defaulted consumer loan will not provide an adequate source of repayment of the outstanding loan.

An unallocated component is maintained to cover uncertainties that could affect management’s estimates of probable losses. The unallocated component of the allowance reflects the margin of imprecision inherent in underlying assumptions used in the methodologies for estimating allocated and general reserves in the portfolio.

‎

10

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2021, and the related portion of the allowances for loan losses that is allocated to each loan class, as of March 31, 2021 (in thousands):

| Residential |  |  | Commercial & Multi-family |  | Construction |  | Commercial Business (1) |  | Home Equity (2) |  | Consumer |  | Unallocated |  | Total
Allowance for loan losses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Beginning Balance, January 1, 2021 | $ | 3,293 |  | $ | 21,772 |  | $ | 1,977 |  | $ | 6,306 |  | $ | 286 |  | $ | - |  | $ | 5 |  | $ | 33,639
Charge-offs: |  | (57) |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | (57)
Recovery: |  | 27 |  |  | - |  |  | - |  |  | - |  |  | 3 |  |  | - |  |  | - |  |  | 30
Provisions: |  | (426) |  |  | 1,347 |  |  | 25 |  |  | 275 |  |  | 4 |  |  | - |  |  | 640 |  |  | 1,865
Ending Balance, March 31, 2021: |  | 2,837 |  |  | 23,119 |  |  | 2,002 |  |  | 6,581 |  |  | 293 |  |  | - |  |  | 645 |  |  | 35,477
Ending Balance attributable to loans: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Individually evaluated for impairment |  | 302 |  |  | 381 |  |  | - |  |  | 4,601 |  |  | 23 |  |  | - |  |  | - |  |  | 5,307
Collectively evaluated for impairment |  | 2,535 |  |  | 22,738 |  |  | 2,002 |  |  | 1,980 |  |  | 270 |  |  | - |  |  | 645 |  |  | 30,170
Ending Balance, March 31, 2021 |  | 2,837 |  |  | 23,119 |  |  | 2,002 |  |  | 6,581 |  |  | 293 |  |  | - |  |  | 645 |  |  | 35,477
Loans Receivables: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Individually evaluated for impairment |  | 5,509 |  |  | 44,086 |  |  | 2,787 |  |  | 13,269 |  |  | 1,693 |  |  | - |  |  | - |  |  | 67,344
Collectively evaluated for impairment |  | 228,866 |  |  | 1,656,027 |  |  | 164,437 |  |  | 164,071 |  |  | 51,667 |  |  | 851 |  |  | - |  |  | 2,265,919
Total Gross Loans: | $ | 234,375 |  | $ | 1,700,113 |  | $ | 167,224 |  | $ | 177,340 |  | $ | 53,360 |  | $ | 851 |  | $ | - |  | $ | 2,333,263
(1) Includes business lines of credit. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(2) Includes home equity lines of credit. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

The following table sets forth the activity in the Company’s allowance for loan losses for the three months ended March 31, 2020 (in thousands):

|  | Residential |  |  | Commercial & Multi-family |  | Construction |  | Commercial Business (1) |  | Home Equity (2) |  | Consumer |  | Unallocated |  | Total
Allowance for loan losses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Beginning Balance, January 1, 2020 |  | $ | 2,722 |  | $ | 15,372 |  | $ | 1,244 |  | $ | 3,790 |  | $ | 333 | - | $ | - |  | $ | 273 |  | $ | 23,734
Charge-offs: |  |  | (4) |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | (4)
Recovery: |  |  | - |  |  | - |  |  | - |  |  | 302 |  |  | 2 |  |  | - |  |  | - |  |  | 304
Provisions: |  |  | 413 |  |  | (423) |  |  | (139) |  |  | (135) |  |  | 290 |  |  | 5 |  |  | 1,489 |  |  | 1,500
Ending Balance March 31, 2020 |  |  | 3,131 |  |  | 14,949 |  |  | 1,105 |  |  | 3,957 |  |  | 625 |  |  | 5 |  |  | 1,762 |  |  | 25,534
Ending Balance attributable to loans: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Individually evaluated for impairment |  |  | 354 |  |  | 332 |  |  | - |  |  | 2,524 |  |  | 22 |  |  | - |  |  | - |  |  | 3,232
Collectively evaluated for impairment |  |  | 2,777 |  |  | 14,617 |  |  | 1,105 |  |  | 1,433 |  |  | 603 |  |  | 5 |  |  | 1,762 |  |  | 22,302
Ending Balance March 31, 2020 |  |  | 3,131 |  |  | 14,949 |  |  | 1,105 |  |  | 3,957 |  |  | 625 |  |  | 5 |  |  | 1,762 |  |  | 25,534
Loans Receivables: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Individually evaluated for impairment |  |  | 8,335 |  |  | 9,895 |  |  | - |  |  | 3,466 |  |  | 1,326 |  |  | - |  |  | - |  |  | 23,022
Collectively evaluated for impairment |  |  | 259,802 |  |  | 1,567,921 |  |  | 101,692 |  |  | 173,680 |  |  | 63,531 |  |  | 1,029 |  |  | - |  |  | 2,167,655
Total Gross Loans: |  | $ | 268,137 |  | $ | 1,577,816 |  | $ | 101,692 |  | $ | 177,146 |  | $ | 64,857 |  | $ | 1,029 |  | $ | - |  | $ | 2,190,677
_____________________________ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(1) Includes business lines of credit. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(2) Includes home equity lines of credit. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

‎

11

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

The following table sets forth the amount recorded in loans receivable at December 31, 2020. The table also details the amount of total loans receivable that are evaluated individually, and collectively, for impairment and the related portion of the allowance for loan losses that is allocated to each loan class (in thousands):

|  | Residential |  |  | Commercial & Multi-family |  |  | Construction |  |  | Commercial Business (1) |  |  | Home Equity (2) |  |  | Consumer |  |  | Unallocated |  |  | Total
Allowance for credit losses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Ending Balance attributable to loans: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Individually evaluated for impairment | $ | 416 |  | $ | 378 |  | $ | - |  | $ | 3,640 |  | $ | 27 |  | $ | - |  | $ | - |  | $ | 4,461
Collectively evaluated for impairment |  | 2,877 |  |  | 21,394 |  |  | 1,977 |  |  | 2,666 |  |  | 259 |  |  | - |  |  | 5 |  |  | 29,178
Ending Balance, December 31, 2020 | $ | 3,293 |  | $ | 21,772 |  | $ | 1,977 |  | $ | 6,306 |  | $ | 286 |  | $ | - |  | $ | 5 |  | $ | 33,639
Loans Receivables: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | -
Individually evaluated for impairment | $ | 7,281 |  | $ | 61,854 |  | $ | - |  | $ | 12,492 |  | $ | 1,574 |  | $ | - |  | $ | - |  | $ | 83,201
Collectively evaluated for impairment |  | 237,088 |  |  | 1,628,982 |  |  | 155,967 |  |  | 171,865 |  |  | 52,093 |  |  | 822 |  |  | - |  |  | 2,246,817
Total Gross Loans: | $ | 244,369 |  | $ | 1,690,836 |  | $ | 155,967 |  | $ | 184,357 |  | $ | 53,667 |  | $ | 822 |  | $ | - |  | $ | 2,330,018

(1) Includes business lines of credit.
(2) Includes home equity lines of credit.

‎

12

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

The following table summarizes the average recorded investment and interest income recognized on impaired loans with no related allowance recorded by portfolio class for the three months ended March 31, 2021 and 2020 (in thousands):

|  | Three Months Ended March 31, |
|  | 2021 |  |  | 2021 |  |  | 2020 |  |  | 2020 |
| Average |  | Interest |  | Average |  | Interest |
| Recorded |  | Income |  | Recorded |  | Income |
| Investment |  | Recognized |  | Investment |  | Recognized |
Loans with no related allowance recorded: |  |  |  |  |  |  |  |  |  |  |  |
Residential one-to-four family | $ | 3,453 |  | $ | 34 |  | $ | 4,656 |  | $ | 52 |
Commercial and Multi-family |  | 44,958 |  |  | 282 |  |  | 10,322 |  |  | 99 |
Construction |  | 1,394 |  |  | 36 |  |  | - |  |  | - |
Commercial business(1) |  | 5,171 |  |  | 13 |  |  | 2,013 |  |  | 43 |
Home equity(2) |  | 1,196 |  |  | 10 |  |  | 848 |  |  | 9 |
Total Impaired Loans with no allowance recorded: | $ | 56,172 |  | $ | 375 |  | $ | 17,839 |  | $ | 203 |
Loans with an allowance recorded: |  |  |  |  |  |  |  |  |  |  |  |
Residential one-to-four family | $ | 2,943 |  | $ | 32 |  | $ | 3,741 |  | $ | 41 |
Commercial and Multi-family |  | 8,013 |  |  | 129 |  |  | 1,241 |  |  | 20 |
Commercial business(1) |  | 7,710 |  |  | 93 |  |  | 1,690 |  |  | 3 |
Home equity(2) |  | 438 |  |  | 2 |  |  | 460 |  |  | 4 |
Consumer |  | - |  |  | - |  |  | - |  |  | - |
Total Impaired Loans with an allowance recorded: | $ | 19,104 |  | $ | 256 |  | $ | 7,132 |  | $ | 68 |
Total Impaired Loans: | $ | 75,276 |  | $ | 631 |  | $ | 24,971 |  | $ | 271 |

__________

(1)Includes business lines of credit.

(2)Includes home equity lines of credit.

(3)Does not include accretable yield on loans acquired with deteriorated credit.

The following table summarizes the recorded investment by portfolio class at March 31, 2021 and December 31, 2020. (in thousands):

|  | As of March 31, 2021 |  |  | As of December 31, 2020
|  | Recorded |  |  | Unpaid Principal |  |  | Related |  |  | Recorded |  |  | Unpaid Principal |  |  | Related
|  | Investment |  |  | Balance |  |  | Allowance |  |  | Investment |  |  | Balance |  |  | Allowance
Loans with no related allowance recorded: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Residential one-to-four family | $ | 2,821 |  | $ | 3,210 |  | $ | - |  | $ | 4,084 |  | $ | 4,660 |  | $ | -
Commercial and multi-family |  | 32,357 |  |  | 33,761 |  |  | - |  |  | 57,558 |  |  | 58,739 |  |  | -
Construction |  | 2,787 |  |  | 2,787 |  |  | - |  |  | - |  |  | - |  |  | -
Commercial business(1) |  | 4,498 |  |  | 12,573 |  |  | - |  |  | 5,844 |  |  | 17,687 |  |  | -
Home equity(2) |  | 1,268 |  |  | 1,270 |  |  | - |  |  | 1,124 |  |  | 1,126 |  |  | -
Total Impaired Loans with no related allowance recorded: | $ | 43,731 |  | $ | 53,601 |  | $ | - |  | $ | 68,610 |  | $ | 82,212 |  | $ | -
Loans with an allowance recorded: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Residential one-to-four family | $ | 2,688 |  | $ | 2,723 |  | $ | 302 |  | $ | 3,197 |  | $ | 3,252 |  | $ | 416
Commercial and Multi-family |  | 11,729 |  |  | 15,584 |  |  | 381 |  |  | 4,296 |  |  | 4,501 |  |  | 378
Commercial business(1) |  | 8,771 |  |  | 20,662 |  |  | 4,601 |  |  | 6,648 |  |  | 12,511 |  |  | 3,640
Home equity(2) |  | 425 |  |  | 425 |  |  | 23 |  |  | 450 |  |  | 458 |  |  | 27
Total Impaired Loans with an allowance recorded: | $ | 23,613 |  | $ | 39,394 |  | $ | 5,307 |  | $ | 14,591 |  | $ | 20,722 |  | $ | 4,461
Total Impaired Loans: | $ | 67,344 |  | $ | 92,995 |  | $ | 5,307 |  | $ | 83,201 |  | $ | 102,934 |  | $ | 4,461

__________

(1) Includes business lines of credit.
‎(2) Includes home equity lines of credit.

‎

13

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

A troubled debt restructured loan (“TDR”) is a loan that has been modified whereby the Company has agreed to make certain concessions to a borrower to meet the needs of both the borrower and the Company to maximize the ultimate recovery of a loan. A TDR occurs when a borrower is experiencing, or is expected to experience, financial difficulties and the loan is modified using a concession that would otherwise not be granted to the borrower. Pursuant to the CARES Act, a loan that was current at December 31, 2019 and modified due to the COVID-19 pandemic is not considered a TDR. The types of concessions granted generally include, but are not limited to, interest rate reductions, limitations on the accrued interest charged, term extensions, and deferment of principal. All TDRs were considered impaired and therefore were individually evaluated for impairment in the calculation of the allowance for loan losses. Prior to their classification as TDRs, certain of these loans had been collectively evaluated for impairment in the calculation of the allowance for loan losses.

|  | At March 31,2021 |  |  | At December 31, 2020
|  | (In thousands)
Recorded investment in TDRs: |  |  |  |  |
Accrual status | $ | 13,474 |  | $ | 13,760
Non-accrual status |  | 1,074 |  |  | 2,303
Total recorded investment in TDRs | $ | 14,548 |  | $ | 16,063

The Company originated one TDR loan totaling $96,532 and one TDR loan totaling $216,102 for the three months ended March 31, 2021 and March 31, 2020, respectively.

For the three months ended March 31, 2021 and March 31, 2020, TDRs, for which there was a payment default within twelve months of restructuring, totaled $127,449 for one loan and $0, respectively.

The following table sets forth the delinquency status of total loans receivable as of March 31, 2021:

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Loans Receivable
| 30-59 Days |  | 60-90 Days |  | Greater Than |  | Total Past |  |  |  |  | Total Loans |  | >90 Days
| Past Due |  | Past Due |  | 90 Days |  | Due |  | Current |  | Receivable |  | and Accruing
|  | (In Thousands)
Residential one-to-four family | $ | 936 |  | $ | - |  | $ | 227 |  | $ | 1,163 |  | $ | 233,212 |  | $ | 234,375 |  | $ | -
Commercial and multi-family |  | 13,148 |  |  | 4,410 |  |  | 2,447 |  |  | 20,005 |  |  | 1,680,108 |  |  | 1,700,113 |  |  | -
Construction |  | 2,787 |  |  | - |  |  | - |  |  | 2,787 |  |  | 164,437 |  |  | 167,224 |  |  | -
Commercial business(1) |  | 457 |  |  | 1,153 |  |  | 4,796 |  |  | 6,406 |  |  | 170,934 |  |  | 177,340 |  |  | -
Home equity(2) |  | 235 |  |  | 39 |  |  | 427 |  |  | 701 |  |  | 52,659 |  |  | 53,360 |  |  | -
Consumer |  | - |  |  | - |  |  | - |  |  | - |  |  | 851 |  |  | 851 |  |  | -
Total | $ | 17,563 |  | $ | 5,602 |  | $ | 7,897 |  | $ | 31,062 |  | $ | 2,302,201 |  | $ | 2,333,263 |  | $ | -

_________

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

The following table sets forth the delinquency status of total loans receivable at December 31, 2020:

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Loans Receivable
| 30-59 Days |  | 60-90 Days |  | Greater Than |  | Total Past |  |  |  |  | Total Loans |  | >90 Days
| Past Due |  | Past Due |  | 90 Days |  | Due |  | Current |  | Receivable |  | and Accruing
|  | (In Thousands)
Originated loans: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Residential one-to-four family | $ | 507 |  | $ | 266 |  | $ | 664 |  | $ | 1,437 |  | $ | 242,932 |  | $ | 244,369 |  | $ | 125
Commercial and multi-family |  | 15,910 |  |  | 2,996 |  |  | 1,334 |  |  | 20,240 |  |  | 1,670,596 |  |  | 1,690,836 |  |  | -
Construction |  | - |  |  | - |  |  | - |  |  | - |  |  | 155,967 |  |  | 155,967 |  |  | -
Commercial business(1) |  | 3,889 |  |  | 904 |  |  | 3,354 |  |  | 8,147 |  |  | 176,210 |  |  | 184,357 |  |  | 133
Home equity(2) |  | 541 |  |  | 12 |  |  | 502 |  |  | 1,055 |  |  | 52,612 |  |  | 53,667 |  |  | 75
Consumer |  | - |  |  | - |  |  | - |  |  | - |  |  | 822 |  |  | 822 |  |  | -
Total | $ | 20,847 |  | $ | 4,178 |  | $ | 5,854 |  | $ | 30,879 |  | $ | 2,299,139 |  | $ | 2,330,018 |  | $ | 333

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

14

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

The table below sets forth the amounts and types of non-accrual loans in the Bank’s loan portfolio at March 31, 2021 and December 31, 2020, respectively. Loans are placed on non-accrual status when they become more than 90 days delinquent, or when the collection of principal and/or interest become doubtful. As of March 31, 2021, and December 31, 2020, non-accrual loans differed from the amount of total loans past due greater than 90 days due to loans which are maintained on non-accrual status for a minimum of six months until the borrower has demonstrated its ability to satisfy the terms of the restructured loan. There were $7.3 million at March 31, 2021 and $11.9 million at December 31, 2020 in nonaccrual loans that were less than ninety days past due. Nonaccrual loans do not include loans acquired with deteriorated credit quality which were recorded at their fair value at acquisition and totaled $884,000 at March 31, 2021 and $1.1 million at December 31, 2020.

|  | As of March 31, 2021 |  |  | As of December 31, 2020
|  | (In Thousands) |  |  | (In Thousands)
Non-Accruing Loans: |  |  |  |  |
Originated loans: |  |  |  |  |
Residential one-to-four family | $ | 701 |  | $ | 1,736
Commercial and multi-family |  | 7,962 |  |  | 8,721
Commercial business(1) |  | 5,307 |  |  | 5,383
Home equity(2) |  | 435 |  |  | 556
Total | $ | 14,405 |  | $ | 16,396

_________

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

Had non-accrual loans been performing in accordance with their original terms, the interest income recognized for the three months ended March 31, 2021 and December 31, 2020 would have been approximately $343,000 and $1.5 million, respectively. The Bank has not committed to lend additional funds to the borrowers whose loans have been placed on nonaccrual status. At March 31, 2021 and December 31, 2020, there were $0 and $333,000, respectively, of loans which were more than ninety days past due and still accruing interest.

‎

15

Note 7 - Loans Receivable and Allowance for Loan Losses (Continued)

Criticized and Classified Assets

Company policies provide for a classification system for problem assets. Under this classification system, problem assets are classified as “substandard,” “doubtful,” or “loss.”

When the Company classifies problem assets, the Company may establish general allowances for loan losses in an amount deemed prudent by management. General allowances represent loss allowances which have been established to recognize the inherent risk associated with lending activities, but which, unlike specific allowances, have not been allocated to particular problem assets. A portion of general loss allowances established to cover possible losses related to assets classified as substandard or doubtful may be included in determining our regulatory capital. Specific valuation allowances for loan losses generally do not qualify as regulatory capital. The loans classified as substandard are secured either by residential real estate, commercial real estate or heavy equipment. The loans that have been classified substandard were classified as such primarily due to payment status, because updated financial information has not been timely provided, or the collateral underlying the loan is in the process of being revalued.

The Company’s internal credit risk grades are based on the definitions currently utilized by the banking regulatory agencies. The grades assigned and definitions are as follows, and loans graded excellent, above average, good and watch list (risk ratings 1-5) are treated as “pass” for grading purposes. The “criticized” risk rating (6) and the “classified” risk ratings (7-9) are detailed below:

6 – Special Mention- Loans currently performing but with potential weaknesses including adverse trends in borrower’s operations, credit quality, financial strength, or possible collateral deficiency.

7 – Substandard- Loans that are inadequately protected by current sound worth, paying capacity, and collateral support. Loans on “nonaccrual” status. The loan needs special and corrective attention.

8 – Doubtful- Weaknesses in credit quality and collateral support make full collection improbable, but pending reasonable factors remain sufficient to defer the loss status.

9 – Loss- Continuance as a bankable asset is not warranted. However, this does not preclude future attempts at partial recovery.

The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of March 31, 2021 (in thousands). As of March 31, 2021, the Company had no loans with the classified rating of doubtful or loss.

| Pass |  | Special Mention |  | Substandard |  | Total
Residential one-to-four family | $ | 232,669 |  | $ | 724 |  | $ | 982 |  | $ | 234,375
Commercial and multi-family |  | 1,622,917 |  |  | 38,464 |  |  | 38,732 |  |  | 1,700,113
Construction |  | 164,437 |  |  | - |  |  | 2,787 |  |  | 167,224
Commercial business(1) |  | 162,408 |  |  | 1,998 |  |  | 12,934 |  |  | 177,340
Home equity(2) |  | 52,617 |  |  | - |  |  | 743 |  |  | 53,360
Consumer |  | 851 |  |  | - |  |  | - |  |  | 851
Total Gross Loans | $ | 2,235,899 |  | $ | 41,186 |  | $ | 56,178 |  | $ | 2,333,263

_________

(1) Includes business lines of credit and PPP loans.

(2) Includes home equity lines of credit.
‎

16

Note 7 - Loans Receivable and Allowance for Loan Losses

The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of December 31, 2020 (In thousands). As of December 31, 2020, the Company had no loans with the classified rating of doubtful or loss.

| Pass |  | Special Mention |  | Substandard |  | Total
Residential one-to-four family | $ | 241,237 |  | $ | 1,087 |  | $ | 2,045 |  | $ | 244,369
Commercial and multi-family |  | 1,631,838 |  |  | 2,152 |  |  | 56,846 |  |  | 1,690,836
Construction |  | 155,967 |  |  | - |  |  | - |  |  | 155,967
Commercial business(1) |  | 173,833 |  |  | 1,497 |  |  | 9,027 |  |  | 184,357
Home equity(2) |  | 53,005 |  |  | - |  |  | 662 |  |  | 53,667
Consumer |  | 822 |  |  | - |  |  | - |  |  | 822
Total Gross Loans | $ | 2,256,702 |  | $ | 4,736 |  | $ | 68,580 |  | $ | 2,330,018

________

(1) Includes business lines of credit.

(2) Includes home equity lines of credit.

‎

17

Note 8 – Stockholders’ Equity

On December 15, 2020, the Company closed a private placement of its Series H 3.5% Noncumulative Perpetual Preferred Stock, resulting in gross proceeds of $2,250,000 for 225 shares.

On September 1, 2020, the Company closed a private placement of its Series H 3.5% Noncumulative Perpetual Preferred Stock, resulting in gross proceeds of $5.9 million for 590 shares.

On August 31, 2020, the Company redeemed all 6,465 outstanding shares of its Series F 6.0% Noncumulative Perpetual Preferred Stock, at their face value of $1,000 per share, for a total redemption amount of $6.5 million.

On August 10, 2020, the Company redeemed all 388 outstanding shares of its Series C 6.0% Noncumulative Perpetual Preferred Stock, at their face value of $10,000 per share, for a total redemption amount of $3.9 million.

On July 13, 2020, the Company closed a private placement of its Series H 3.5% Noncumulative Perpetual Preferred Stock, resulting in gross proceeds of $3.1 million for 308 shares, effective June 29, 2020.

Note 9 – Bank Owned Life Insurance

The Bank purchased $60 million of bank owned life insurance (“BOLI”) in August, 2020 and an additional $8.5 million in January, 2021. BOLI involves life insurance purchased by the Bank on a chosen group of employees, and the Bank is owner and beneficiary of the policies. At March 31, 2021, the Bank had $70.2 million in BOLI. BOLI is accounted for using the cash surrender value method and is recorded at its net realizable value.

Note 10 – Goodwill and Other Intangible Assets

The Company’s intangible assets consist of goodwill and core deposit intangibles in connection with the acquisition of IA Bancorp, Inc. as of April 17, 2018. The initial recording of goodwill and other intangible assets requires subjective judgments concerning estimates of the fair value of the acquired assets and assumed liabilities. Goodwill is not amortized but is subject to annual tests for impairment or more often if events or circumstances indicate it may be impaired.

The Company’s core deposit intangibles are amortized on an accelerated basis using an estimated life of 10 years and in accordance with U.S. GAAP are evaluated annually for impairment. An impairment loss will be recognized if the carrying amount of the intangible asset is not recoverable and exceeds fair value. The carrying amount of the intangible asset is not considered recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use of the asset.

The Company believes that the fair values of our goodwill and other intangible assets were in excess of their carrying amounts and there was no impairment at March 31, 2021.

Amortization expense of the core deposit intangibles was $16,000 and $18,000 for the three months ended March 31, 2021 and 2020 respectively. The unamortized balance of the core deposit intangibles and the amount of goodwill at March 31, 2021 was $219,000 and $5.2 million, respectively. The unamortized balance of the core-deposit intangibles and the amount of goodwill at March 31, 2020 was $281,000 and $5.2 million, respectively.
‎

18

Note 11 – Fair Values of Financial Instruments

Guidance on fair value measurements establishes a fair value hierarchy that prioritizes the inputs to valuation methods used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

Level 2: Quoted prices in markets that are not active, or inputs that are observable either directly or indirectly, for substantially the full term of the asset or liability.

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported with little or no market activity).

An asset or liability’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.

The only assets or liabilities that the Company measured at fair value on a recurring basis were as follows. (In thousands):

|  |  |  |  | (Level 1) |  | (Level 2) |  |
|  |  |  |  | Quoted Prices in |  | Significant |  | (Level 3)
|  |  |  |  | Active Markets |  | Other |  | Significant
|  |  |  |  | for Identical |  | Observable |  | Unobservable
Description |  | Total |  | Assets |  | Inputs |  | Inputs
As of March 31, 2021: |  |  |  |  |  |  |  |  |  |  |  |
Securities |  |  |  |  |  |  |  |  |  |  |  |
Debt Securities Available for Sale |  | $ | 93,582 |  | $ | - |  | $ | 93,582 |  | $ | -
Marketable Equities |  | $ | 18,278 |  | $ | 18,278 |  | $ | - |  | $ | -
Total Securities |  | $ | 111,860 |  | $ | 18,278 |  | $ | 93,582 |  | $ | -
As of December 31, 2020: |  |  |  |  |  |  |  |  |  |  |  |
Securities |  |  |  |  |  |  |  |  |  |  |  |
Debt Securities Available for Sale |  | $ | 99,756 |  | $ | - |  | $ | 99,756 |  | $ | -
Marketable Equities |  | $ | 17,717 |  | $ | 17,717 |  | $ | - |  | $ | -
Total Securities |  | $ | 117,473 |  | $ | 17,717 |  | $ | 99,756 |  | $ | -

The Company’s policy is to recognize transfers between levels as of the actual date of the event or change in circumstances that caused the transfer. There were no transfers of assets or liabilities into or out of Level 1, Level 2, or Level 3 of the fair value hierarchy during the three months ended March 31, 2021 and 2020.

The only assets or liabilities that the Company measured at fair value on a nonrecurring basis were as follows. (In thousands):

|  |  |  |  | (Level 1) |  | (Level 2) |  |  |
|  |  |  |  | Quoted Prices in |  | Significant |  | (Level 3)
|  |  |  |  | Active Markets |  | Other |  | Significant
|  |  |  |  | for Identical |  | Observable |  | Unobservable
Description |  | Total |  | Assets |  | Inputs |  | Inputs
As of March 31, 2021 |  |  |  |  |  |  |  |  |  |  |  |
Impaired Loans |  | $ | 18,306 |  | $ | - |  | $ | - |  | $ | 18,306
Other real estate owned |  | $ | 414 |  | $ | - |  | $ | - |  | $ | 414
As of December 31, 2020: |  |  |  |  |  |  |  |  |  |  |  |
Impaired Loans |  | $ | 10,130 |  | $ | - |  | $ | - |  | $ | 10,130
Other real estate owned |  | $ | 414 |  | $ | - |  | $ | - |  | $ | 414

‎

19

Note 11 – Fair Values of Financial Instruments (Continued)

The following tables present additional quantitative information as of March 31, 2021 and December 31, 2020 about assets measured at fair value on a nonrecurring basis and for which the Company has utilized adjusted Level 3 inputs to determine fair value. (Dollars in thousands):

Quantitative Information about Level 3 Fair Value Measurements
|  | Fair Value | Valuation | Unobservable |
|  | Estimate | Techniques | Input | Range
March 31, 2021: |  |  |  |  |
Impaired Loans | $ | 18,306 | Appraisal of collateral (1) | Appraisal adjustments (2) | 0%-10%
Other real estate owned | $ | 414 | Appraisal of collateral (1) | Appraisal adjustments (2) | 0%-10%

|  | Fair Value | Valuation | Unobservable |
|  | Estimate | Techniques | Input | Range
December 31, 2020: |  |  |  |  |
Impaired Loans | $ | 10,130 | Appraisal of collateral (1) | Appraisal adjustments (2) | 0%-10%
Other real estate owned | $ | 414 | Appraisal of collateral (1) | Appraisal adjustments (2) | 0%-10%

(1)Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various level 3 inputs which are not objectively determinable.

(2)Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal.

The following information should not be interpreted as an estimate of the fair value of the entire Company since a fair value calculation is only provided for a limited portion of the Company’s assets and liabilities. Due to a wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Company’s disclosures and those of other companies may not be meaningful. The following methods and assumptions were used to estimate the fair values of the Company’s financial instruments as of March 31, 2021 and December 31, 2020.

Cash and Cash Equivalents and Interest-Earning Time Deposits (Carried at Cost)

The carrying amounts reported in the consolidated statements of financial condition for cash and short-term instruments approximate fair values.

Securities Available for Sale

The fair value of securities available for sale (carried at fair value) are determined by matrix pricing (Level 2), which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted market prices for the specific securities but rather by relying on the securities’ relationship to other benchmark quoted prices.

Equity Securities

The fair values of available-for-sale securities are based on quoted market prices (Level 1).

Loans Held for Sale (Carried at Lower of Cost or Fair Value)

The fair value of loans held for sale is determined, when possible, using quoted secondary-market prices. If no such quoted prices exist, the fair value of a loan is determined using quoted prices for a similar loan or loans, adjusted for specific attributes of that loan. Loans held for sale are carried at the lower of cost or fair value.

Loans Receivable (Carried at Cost)

The fair values of loans, except for certain impaired loans, are estimated using discounted cash flow analyses, using market rates at the date of the Statement of Financial Condition that reflect the credit and interest rate-risk inherent in the loans. Projected future cash flows are calculated based upon contractual maturity or call dates, projected repayments and prepayments of principal. Generally, for variable rate loans that reprice frequently and with no significant change in credit risk, fair values are based on carrying values.
‎

20

Note 11 – Fair Values of Financial Instruments (Continued)

Impaired Loans (Generally Carried at Fair Value)

Impaired loans are those for which the Company has measured and recorded an impairment generally based on the fair value of the loan’s collateral, less estimated costs to sell. Fair value is generally determined based upon independent third-party appraisals of the properties, or discounted cash flows based upon the expected proceeds. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements. The fair value at March 31, 2021 and December 31, 2020 consisted of the loan balances of $23.6 million net of a valuation allowance of $5.3 million and $14.6 million net of a valuation of loan allowance of $4.4 million, respectively.

Other Real Estate Owned (Generally Carried at Lower of Cost or Fair Value)

Real Estate Owned is generally carried at fair value less estimated costs to sell which is determined based upon independent third-party appraisals of the properties or based upon the expected proceeds from a pending sale. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements.

FHLB of New York Stock (Carried at Cost)

The carrying amount of restricted investment in bank stock approximates fair value and considers the limited marketability of such securities.

Interest Receivable and Payable (Carried at Cost)

The carrying amount of interest receivable and interest payable approximates its fair value.

Deposits (Carried at Cost)

The fair values disclosed for demand deposits (e.g., interest and non-interest checking, passbook savings and money market accounts) are, by definition, equal to the amount payable on demand at the reporting date (i.e., their carrying amounts). Fair values for fixed-rate certificates of deposit are estimated using a discounted cash flow calculation that applies interest rates currently being offered in the market on certificates to a schedule of aggregated expected monthly maturities on time deposits.

Borrowings and Subordinated Debt (Carried at Cost)

Fair values are estimated using discounted cash flow analysis, based on quoted prices for new long-term debt with similar credit risk characteristics, terms and remaining maturity. Prices obtained from this active market represent a market value that is deemed to represent the transfer price if the liability were assumed by a third party.

Off-Balance Sheet Financial Instruments (Carried at Cost)

Fair values for the Company’s off-balance sheet financial instruments (lending commitments and unused lines of credit) are based on fees currently charged in the market to enter into similar agreements, taking into account, the remaining terms of the agreements and the counterparties’ credit standing. The fair value of these commitments was deemed immaterial and is not presented in the accompanying table.

‎

21

Note 11 – Fair Values of Financial Instruments (Continued)

The carrying values and estimated fair values of financial instruments were as follows as of March 31, 2021 and December 31, 2020:

|  |  | As of March 31, 2021
|  |  |  |  |  |  |  | Quoted Prices in Active |  | Significant |  | Significant
|  | Carrying |  |  |  |  | Markets for Identical Assets |  | Other Observable Inputs |  | Unobservable Inputs
|  | Value |  | Fair Value |  | (Level 1) |  | (Level 2) |  | (Level 3)
|  | (In Thousands)
Financial assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 296,938 |  | $ | 296,938 |  | $ | 296,938 |  | $ | - |  | $ | -
Interest-earning time deposits |  |  | 735 |  |  | 735 |  |  | - |  |  | 735 |  |  | -
Debt securities available for sale |  |  | 93,582 |  |  | 93,582 |  |  | - |  |  | 93,582 |  |  | -
Equity investments |  |  | 18,278 |  |  | 18,278 |  |  | 18,278 |  |  | - |  |  | -
Loans held for sale |  |  | 1,147 |  |  | 1,147 |  |  | - |  |  | 1,147 |  |  | -
Loans receivable, net |  |  | 2,296,434 |  |  | 2,294,631 |  |  | - |  |  | - |  |  | 2,294,631
FHLB of New York stock, at cost |  |  | 8,920 |  |  | 8,920 |  |  | - |  |  | 8,920 |  |  | -
Accrued interest receivable |  |  | 12,056 |  |  | 12,056 |  |  | - |  |  | 12,056 |  |  | -
Other Real Estate Owned |  |  | 414 |  |  | 414 |  |  | - |  |  | - |  |  | 414
Financial liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deposits |  |  | 2,404,135 |  |  | 2,408,469 |  |  | 1,719,149 |  |  | 689,320 |  |  | -
Borrowings |  |  | 133,298 |  |  | 131,806 |  |  | - |  |  | 131,806 |  |  | -
Subordinated debentures |  |  | 37,101 |  |  | 36,686 |  |  | - |  |  | 36,686 |  |  | -
Accrued interest payable |  |  | 807 |  |  | 807 |  |  | - |  |  | 807 |  |  | -

|  |  | As of December 31, 2020
|  |  |  |  |  |  |  | Quoted Prices in Active |  | Significant |  | Significant
|  | Carrying |  |  |  |  | Markets for Identical Assets |  | Other Observable Inputs |  | Unobservable Inputs
|  | Value |  | Fair Value |  | (Level 1) |  | (Level 2) |  | (Level 3)
|  | (In Thousands)
Financial assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 261,229 |  | $ | 261,229 |  | $ | 261,229 |  | $ | - |  | $ | -
Interest-earning time deposits |  |  | 735 |  |  | 735 |  |  | - |  |  | 735 |  |  | -
Debt securities available for sale |  |  | 99,756 |  |  | 99,756 |  |  | - |  |  | 99,756 |  |  | -
Equity investments |  |  | 17,717 |  |  | 17,717 |  |  | 17,717 |  |  | - |  |  | -
Loans held for sale |  |  | 3,530 |  |  | 3,530 |  |  | - |  |  | 3,530 |  |  | -
Loans receivable, net |  |  | 2,295,021 |  |  | 2,309,118 |  |  | - |  |  | - |  |  | 2,309,118
FHLB of New York stock, at cost |  |  | 11,324 |  |  | 11,324 |  |  | - |  |  | 11,324 |  |  | -
Accrued interest receivable |  |  | 12,924 |  |  | 12,924 |  |  | - |  |  | 12,924 |  |  | -
Other Real Estate Owned |  |  | - |  |  | - |  |  | - |  |  | - |  |  | -
Financial liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deposits |  |  | 2,318,050 |  |  | 2,323,561 |  |  | 1,627,871 |  |  | 695,690 |  |  | -
Borrowings |  |  | 191,161 |  |  | 194,899 |  |  | - |  |  | 194,899 |  |  | -
Subordinated debentures |  |  | 37,042 |  |  | 37,252 |  |  | - |  |  | 37,252 |  |  | -
Accrued interest payable |  |  | 1,463 |  |  | 1,463 |  |  | - |  |  | 1,463 |  |  | -

‎

22

Note 12 – Subordinated debt

On July 30, 2018, the Company issued $33.5 million of fixed-to-floating rate subordinated debentures (the “Notes”) in a private placement. The Notes have a ten-year term and bear interest at a fixed annual rate of 5.625% for the first five years of the term (the "Fixed Interest Rate Period"). From and including August 1, 2023, the interest rate will adjust to a floating rate based on the three-month LIBOR plus 2.72% until redemption or maturity (the "Floating Interest Rate Period"). The Notes are scheduled to mature on August 1, 2028. Subject to limited exceptions, the Company cannot redeem the Notes for the first five years of the term. The Company will pay interest in arrears semi-annually during the Fixed Interest Rate Period and quarterly during the Floating Interest Rate Period during the term of the Notes. The Notes constitute an unsecured and subordinated obligation of the Company and rank junior in right of payment to any senior indebtedness and obligations to general and secured creditors. The Notes qualify as Tier 2 capital for the Company for regulatory purposes, when applicable, and the portion that the Company contributes to the Bank will qualify as Tier 1 capital for the Bank. The additional capital will be used for general corporate purposes including organic growth initiatives. Subordinated debt includes associated deferred costs of $523,000 and $911,000 at March 31, 2021 and December 31, 2020, respectively.

The Company also has $4,124,000 of mandatory redeemable trust preferred securities. The interest rate on these floating rate junior subordinated debentures adjusts quarterly, equal to the three-month LIBOR and 2.65%.

As it is anticipated that LIBOR will be discontinued after 2021, the Company is reviewing the agreements for the above debentures to determine alternative reference rates and does not anticipate there will be a significant financial statement impact.

Note 13 – Lease Obligations

The Company leases 28 of its offices under various operating lease agreements. The leases have remaining terms of one year to 12 years. The leases contain provisions for the payment by the Company of its pro-rata share of real estate taxes, insurance, common area maintenance and other variable expenses. The Company will allocate payments made under such leases between lease and non-lease components. Some leases contain renewal options and options to purchase the assets.

The Company has elected not to recognize a lease liability and a right of use asset for leases with a lease term of 12 or fewer months.

The following tables present certain information related to the Company’s leases (in thousands):

|  | Three Months Ended March 31, 2021 |  |  | Three Months Ended March 31, 2020
Operating lease cost | $ | 952 |  | $ | 854
Variable lease cost-operating leases | $ | 246 |  | $ | 202
|  | At March 31, 2021 |  |  | At December 31, 2020
Supplemental balance sheet information related to leases: |  |  |  |  |
Operating Leases |  |  |  |  |
Operating lease right-of-use assets | $ | 14,328 |  | $ | 14,988
Current liabilities | $ | 3,020 |  | $ | 2,992
Operating lease liabilities (noncurrent portion) |  | 11,569 |  |  | 12,232
Total operating lease liabilities | $ | 14,589 |  | $ | 15,224

The weighted average remaining lease term for operating leases at March 31, 2021 and December 31, 2020 was 6.40 years and 6.57 years, respectively. The weighted average discount rate for operating leases at March 31, 2021 and December 31, 2020 was 2.65 percent and 2.67 percent, respectively.

The following table summarizes the Company’s maturity of lease obligations for operating leases at March 31, 2021 and December 31, 2020 (in thousands):

Maturities of lease liabilities:
|  | At March 31, 2021 |  |  | At December 31, 2020
|  | Operating Leases |  |  | Operating Leases
One year or less | $ | 3,358 |  | $ | 3,348
Over one year through three years |  | 5,225 |  |  | 5,424
Over three years through five years |  | 3,269 |  |  | 3,459
Over five years |  | 4,065 |  |  | 4,415
Gross Operating Lease Liabilities | $ | 15,917 |  | $ | 16,646
Deferred Expenses |  | (1,328) |  |  | (1,422)
Total Operating Lease Liabilities | $ | 14,589 |  | $ | 15,224

Note 14 – Subsequent Events

On April 14, 2021, the Board of Directors of the Company declared a cash dividend of $0.14 per share to shareholders of record of its common stock on May 10, 2021 with a payment date of May 24, 2021.

ITEM 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This report on Form 10-Q contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995, or the PSLRA. Such forward-looking statements, in addition to historical information, involve risk and uncertainties, and are based on the beliefs, assumptions and expectations of our management team. Words such as “expects,” “believes,” “should,” “plans,” “anticipates,” “will,” “potential,” “could,” “intend,” “may,” “outlook,” “predict,” “project,” “would,” “estimated,” “assumes,” “likely,” and variation of such similar expressions are intended to identify such forward-looking statements. Forward-looking statements speak only as of the

23

date they are made. Because forward-looking statements are subject to assumptions and uncertainties, actual results or future events could differ, possibly materially, from those that we anticipated in our forward-looking statements and future results could differ materially from historical performance.

Factors that could cause future results to vary from current management expectations as reflected in our forward-looking statements include, but are not limited to:

unfavorable economic conditions in the United States generally and particularly in our primary market area;

the effects of declines in housing markets and real estate values that may adversely impact the collateral underlying our loans;

increase in unemployment levels and slowdowns in economic growth;

our level of non-performing assets and the costs associated with resolving any problem loans including litigation and other costs;

the impact of changes in interest rates and the credit quality and strength of underlying collateral and the effect of such changes on the market value of our loan and investment securities portfolios;

the credit risk associated with our loan portfolio;

changes in the quality and composition of the Bank’s loan and investment portfolios;

changes in our ability to access cost-effective funding;

deposit flows;

legislative and regulatory changes, including increases in Federal Deposit Insurance Corporation, or FDIC, insurance rates;

monetary and fiscal policies of the federal and state governments;

changes in tax policies, rates and regulations of federal, state and local tax authorities;

inflation;

demands for our loan products;

demand for financial services;

competition;

changes in the securities or secondary mortgage markets;

changes in management’s business strategies;

our ability to enter new markets successfully;

our ability to successfully integrate acquired businesses;

changes in consumer spending;

our ability to retain key employees;

the effects of any reputational, credit, interest rate, market, operational, legal, liquidity, or regulatory risk;

expanded regulatory requirements as a result of the Dodd-Frank Wall Street Reform and Consumer Protection Act, which could adversely affect operating results;

civil unrest in the communities that we serve;

the global spread of the Coronavirus Disease 2019 (“COVID-19”) and the impact that it is having on the United States, in general, and New Jersey and New York, in particular (see Item 1.A. Risk Factors in the Company’s Annual Report on Form 10-K); and

other factors discussed elsewhere in this report, and in other reports we filed with the SEC, including under “Risk Factors” in Part I, Item 1A of our annual Report on Form 10-K, in Part II, Item 1A of our quarterly reports on Form 10-Q, and our other periodic reports that we file with the SEC.

You should not place undue reliance on these forward-looking statements, which reflect our expectations only as of the date of this Form 10-Q. We do not assume any obligation to revise forward-looking statements except as may be required by law.

Overview

BCB Bancorp, Inc. is a New Jersey corporation, and is the holding company parent of BCB Community Bank, or the Bank. The Company has not engaged in any significant business activity other than owning all of the outstanding common stock of BCB Community Bank. Our executive office is located at 104-110 Avenue C, Bayonne, New Jersey 07002. At March 31, 2021, we had approximately $2.852 billion in consolidated assets, $2.404 billion in deposits and $253.4 million in consolidated stockholders’ equity.

BCB Community Bank opened for business on November 1, 2000 as Bayonne Community Bank, a New Jersey chartered commercial bank. The Bank changed its name from Bayonne Community Bank to BCB Community Bank in April 2007. At March 31, 2021, the Bank operated through 29 branches in Bayonne, Carteret, Edison, Jersey City, Hoboken, Fairfield, Holmdel, Lyndhurst, Maplewood, Monroe Township, Newark, Parsippany, Plainsboro, River Edge, Rutherford, South Orange, Union, and Woodbridge, New Jersey, as well as three branches in Hicksville and Staten Island, NY, and through executive offices located at 104-110 Avenue C and an administrative office located at 591-595 Avenue C, Bayonne, New Jersey 07002. The Bank’s deposit accounts are insured by the FDIC, and the Bank is a member of the Federal Home Loan Bank System.

We are a community-oriented financial institution. Our business is to offer FDIC-insured deposit products and to invest funds held in deposit accounts at the Bank, together with funds generated from operations, in loans and investment securities. We offer our customers:

loans, including commercial and multi-family real estate loans, one- to four-family mortgage loans, home equity loans, construction loans, consumer loans and commercial business loans. In recent years the primary growth in our loan portfolio has been in loans secured by commercial real estate and multi-family properties;

FDIC-insured deposit products, including savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts; and

retail and commercial banking services including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, mobile banking, gift cards, fraud detection (positive pay), and automated teller services.

Critical Accounting Policies

The preparation of the Consolidated Financial Statements in accordance with U.S. GAAP requires us to make estimates and assumptions affecting the reported amounts of assets, liabilities, revenues and expenses. We regularly evaluate these estimates and assumptions including those used to determine the allowance for loan losses, deferred taxes, fair value measurements, goodwill and other intangible assets. We base our estimates on historical experience and various other factors and assumptions that are believed to be reasonable under the circumstances. These form the basis for making judgments on the carrying value of assets and liabilities that are not readily apparent from other sources. Although our current estimates contemplate current economic conditions and how we expect them to change in the future, for the remainder of 2021, it is reasonably possible that actual conditions may be worse than anticipated in those estimates, which could materially affect our results of operations and financial condition. Actual results may differ from these estimates under different assumptions or conditions.

24

See further discussion of these critical accounting policies in our Annual Report on Form 10-K for the year ended December 31, 2020 and Note 2, Basis of Presentation, to the unaudited Consolidated Financial Statements. There has been no change in critical accounting policies since the Company’s last annual report on Form 10-K.

COVID-19 Overview

With the global outbreak of COVID-19, the Company remains focused on protecting the health and wellbeing of its employees and the communities in which it operates while assuring the continuity of its business operations.

The Company activated its dedicated pandemic team that proactively implemented its business continuity plans and has taken a variety of measures to ensure the ongoing availability of services, while taking health and safety measures, including enhanced cleaning and hygiene protocols in all of its facilities and remote work policies, where possible. To date, as a result of these business continuity measures, the Company has not experienced significant disruptions in its operations.

As of March 31, 2021, the Company had $297 million of cash on hand and available wholesale borrowing capacity of over $800 million.

COVID-19 Response

Operational Initiatives

o The pandemic response team meets on an as-needed basis and actively monitors guidance released by regulators and banking associations.

o In-person meetings are closely managed and are held on an as needed basis only.

o Many employees are working remotely, temporarily relocated or are working alternate days to increase social distancing.

o Barriers have been installed in branches and back offices to provide protection.

o Branch and operational offices are cleaned and sanitized biweekly and employees have access to masks, gloves and disinfectant.

o Masks are required for entry and social distancing is strictly enforced.

o Management provides updates to employees on a regular basis.

o The Call Center is open six days a week to assist with customer inquiries.

o Branch offices are open; however, customers have the ability to make an appointment if they choose. The Bank is encouraging customers to utilize the ATM, drive-through and electronic banking services wherever possible.

o The Bank is working with a local provider to have the vaccine administered at one of the Bank’s locations for its interested employees.

Allowance for Loan Losses (“ALLL”)

o The Bank increased its loan loss reserves through the addition of $1.9 million in loan loss provisions for the three-month period ending March 31, 2021, as compared to $1.5 million for the same period last year. The Bank considered qualitative factors, such as changes in underwriting policies, current economic conditions, delinquency statistics, the adequacy of the underlying collateral and the financial strength of borrowers in arriving at its loan loss provision. All of these factors are likely to be affected by the COVID-19 pandemic. Loan categories for specific business types were stressed due to rising delinquencies within those market sectors (hospitality, restaurants, office space, and commercial condos) to determine the potential for collateral shortfalls. The impact of COVID-19 is likely to be felt over the next several quarters. Adjustments to the ALLL may be required as the full impact of COVID-19 on the borrowers’ capacity to make payments and the value of the underlying collateral becomes known.

Loan Deferments

o The banking regulatory agencies, through an Interagency Statement dated April 7, 2020, encouraged financial institutions to work prudently with borrowers who request loan modifications or deferrals as a result of COVID-19. The Bank did so in 2020, but now has no deferred loans within its portfolio.

o The Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, was signed into law on March 27, 2020, and provided over $2.0 trillion in emergency economic relief to individuals and businesses impacted by the COVID-19 pandemic. Under Section 4013 of the CARES Act, loans less than 30 days past due as of December 31, 2019 will be considered current for COVID-19 modifications. A financial institution can then suspend the requirements under GAAP for loan modifications related to COVID-19 that would otherwise be categorized as a TDR, and suspend any determination of a loan modified as a result of COVID-19 as being a TDR, including the requirement to determine impairment for accounting purposes. Most of these loans are accruing interest and the Bank is considering the loans within the overall allowance for loan loss analysis.

o The Consolidated Appropriations Act of 2021, signed into law on December 27, 2020, extends these provisions through January 1, 2022.

o The Bank has worked with customers that previously requested loan deferments and entered into COVID-19 modifications. The loan balances for these customers at March 31, 2021 was approximately $86.2 million. The modifications generally provide a short-term, interest-only period. The Bank does not believe that these modified loans will result in losses, so long as the borrowers' representation of cash flows is realized. Borrowers that have requested modifications with less definitive cash flow projections have been denied and are being analyzed as part of the loan stress testing and Allowance for Loan Loss calculation.

Paycheck Protection Program (PPP)

o The Bank has partnered with The Loan Source, Inc. and recognized $328,000 in brokered referral fees for the second round of PPP loans that they originated in the first quarter of 2021.

IT Changes

o To protect the well-being of our staff and customers, the Company has set up resources for some employees to work from home. To facilitate the move, we allocated laptop computers to staff and enhanced our ability to access the network offsite. We have taken additional steps to minimize the increased risk of security breaches (including privacy breaches and cyber-attacks), given the increased number of employees working remotely.

Liquidity and Capital Resources

o The Company was well positioned with adequate levels of cash and liquid assets as of March 31, 2021, as well as wholesale borrowing capacity of over $800 million. At March 31, 2021, the Company’s equity to assets ratio was 8.89 percent and the Bank is considered “well capitalized” under its regulatory requirements. The Company will continue to monitor the effects of COVID-19 in determining future cash dividends and any requirement for additional capital each quarter.

‎

25

Financial Condition

Total assets increased by $31.4 million, or 1.1 percent, to $2.852 billion at March 31, 2021 from $2.821 billion at December 31, 2020. The increase in total assets was mainly related to an increase in total cash and cash equivalents, partly offset by a decrease in investment securities.

Total cash and cash equivalents increased by $35.7 million, or 13.7 percent, to $296.9 million at March 31, 2021 from $261.2 million at December 31, 2020. This increase was mainly related to an increase in deposits, partly offset by net repayments of borrowings.

Loans receivable, net increased by $1.4 million, or 0.1 percent, to $2.296 billion at March 31, 2021 from $2.295 billion at December 31, 2020. Total loan increases for the three months ended March 31, 2021 included increases of $11.2 million in construction loans, $9.3 million in commercial real estate and multi-family loans, $29,000 in consumer loans, partly offset by decreases of $10.0 million in residential one-to-four family loans, $7.0 million in commercial business loans, and $307,000 in home equity loans. The allowance for loan losses increased $1.8 million to $35.5 million, or 246.3 percent of non-accruing loans and 1.52 percent of gross loans, at March 31, 2021 as compared to an allowance for loan losses of $33.6 million, or 205.2 percent of non-accruing loans and 1.44 percent of gross loans, at December 31, 2020.

Total investment securities decreased by $5.6 million, or 4.8 percent, to $111.9 million at March 31, 2021 from $117.5 million at December 31, 2020, representing repayments, calls and maturities, partly offset by purchases of $757,000.

Deposit liabilities increased by $86.1 million, or 3.7 percent, to $2.404 billion at March 31, 2021 from $2.318 billion at December 31, 2020. The increase in deposit liabilities mainly related to the recent payments to individuals under the American Rescue Plan and the second round of PPP payments under the Consolidated Appropriations Act of 2021. Total increases for the three months ended March 31, 2021 included $52.0 million in non-interest-bearing deposit accounts, $20.2 million in money market checking accounts, $13.5 million in savings and club accounts, and $6.3 million in NOW deposit accounts. The increase in deposits was partly offset by decreases of $5.9 million in certificates of deposit, including listing service and brokered deposit accounts. The Company utilizes listing service and brokered certificates of deposit as additional sources of deposit liquidity to fund loan growth. At March 31, 2021, the Company had $17.0 million in listing service deposits and no brokered certificates of deposit.

Debt obligations decreased by $57.8 million, or 25.3 percent, to $170.4 million at March 31, 2021 from $228.2 million at December 31, 2020. The weighted average interest rate of FHLB advances was 1.40 percent at March 31, 2021 and 1.66 percent at December 31, 2020. The fixed interest rate of our subordinated debt balances was 5.625 percent at March 31, 2021 and December 31, 2020. During the three months ended March 31, 2021, the Company opted to extinguish $53.0 million in FHLB advances which held a weighted average rate of 1.83%, and repaid a scheduled maturity of $15.0 million on March 1, 2021, which was at 2.61%. The advances were originally set to mature in 2021 and 2022. The effect of the extinguishment of the debt reduced the weighted average cost of FHLB borrowings by approximately 20 basis points on an annualized basis. The related expense for the extinguishment of this debt is included in noninterest expense.

Stockholders’ equity increased by $4.3 million, or 1.7 percent, to $253.5 million at March 31, 2021 from $249.2 million at December 31, 2020. The increase was primarily attributable to the increase in retained earnings of $4.4 million, or 7.6 percent, to $62.8 million at March 31, 2021 from $58.4 million at December 31, 2020, related to the net effect of net income less dividends paid for the three months ended March 31, 2021.

Net Interest Income Analysis

Net interest income represents the difference between income earned on our interest-earning assets and the expense incurred on our interest-bearing liabilities, and is analyzed and monitored by the Company on a regular basis. The following tables set forth average balance sheets, yields, and costs. The yields include the effect of deferred fees, discounts, and premiums that are amortized or accreted to interest income or expense.

|  |  | Three Months Ended March 31,
|  |  | 2021 |  |  | 2020
|  |  | Average Balance |  |  | Interest Earned/Paid |  | Average Yield/Rate (3) |  |  | Average Balance |  |  | Interest Earned/Paid |  | Average Yield/Rate (3)
|  |  | (Dollars in thousands)
Interest-earning assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans Receivable |  | $ | 2,326,230 |  | $ | 26,863 |  | 4.62% |  | $ | 2,185,753 |  | $ | 26,814 |  | 4.91%
Investment Securities |  |  | 114,461 |  |  | 990 |  | 3.46% |  |  | 92,306 |  |  | 571 |  | 2.47%
FHLB Stock and interest earnings assets |  |  | 264,308 |  |  | 222 |  | 0.34% |  |  | 580,623 |  |  | 2,034 |  | 1.40%
Total Interest-earning assets |  |  | 2,704,999 |  |  | 28,075 |  | 4.15% |  |  | 2,858,682 |  |  | 29,419 |  | 4.12%
Non-interest-earning assets |  |  | 109,987 |  |  |  |  |  |  |  | 73,509 |  |  |  |  |
Total assets |  | $ | 2,814,986 |  |  |  |  |  |  | $ | 2,932,191 |  |  |  |  |
Interest-bearing liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest-bearing demand accounts |  | $ | 610,893 |  | $ | 757 |  | 0.50% |  | $ | 407,339 |  | $ | 858 |  | 0.84%
Money market accounts |  |  | 317,151 |  |  | 441 |  | 0.56% |  |  | 321,233 |  |  | 1,350 |  | 1.68%
Savings accounts |  |  | 302,741 |  |  | 118 |  | 0.16% |  |  | 259,721 |  |  | 105 |  | 0.16%
Certificates of Deposit |  |  | 682,975 |  |  | 1,992 |  | 1.17% |  |  | 1,120,060 |  |  | 6,432 |  | 2.30%
Total interest-bearing deposits |  |  | 1,913,760 |  |  | 3,308 |  | 0.69% |  |  | 2,108,353 |  |  | 8,745 |  | 1.66%
Borrowed funds |  |  | 205,956 |  |  | 1,205 |  | 2.34% |  |  | 284,830 |  |  | 1,896 |  | 2.66%
Total interest-bearing liabilities |  |  | 2,119,716 |  |  | 4,513 |  | 0.85% |  |  | 2,393,183 |  |  | 10,641 |  | 1.78%
Non-interest-bearing liabilities |  |  | 444,787 |  |  |  |  |  |  |  | 299,679 |  |  |  |  |
Total liabilities |  |  | 2,564,503 |  |  |  |  |  |  |  | 2,692,862 |  |  |  |  |
Stockholders' equity |  |  | 250,483 |  |  |  |  |  |  |  | 239,329 |  |  |  |  |
Total liabilities and stockholders' equity |  | $ | 2,814,986 |  |  |  |  |  |  | $ | 2,932,191 |  |  |  |  |
Net interest income |  |  |  |  | $ | 23,562 |  |  |  |  |  |  | $ | 18,778 |  |
Net interest rate spread(1) |  |  |  |  |  |  |  | 3.30% |  |  |  |  |  |  |  | 2.34%
Net interest margin(2) |  |  |  |  |  |  |  | 3.48% |  |  |  |  |  |  |  | 2.63%

(1)Net interest rate spread represents the difference between the average yield on average interest-earning assets and the average cost of average interest-bearing liabilities.

(2)Net interest margin represents net interest income divided by average total interest-earning assets.

(3)Annualized.

26

Results of Operations comparison for the Three Months Ended March 31, 2021 and 2020

Net income increased by $4.6 million, or 182.3 percent, to $7.1 million for the three months ended March 31, 2021 from $2.5 million for the three months ended March 31, 2020. The increase in net income was primarily related to a decrease in total interest expense, an increase in total noninterest income, a decrease in total noninterest expense, partly offset by a decrease in interest income, an increase in the provision for loan losses and an increase in the income tax provision for the three months ended March 31, 2021 as compared to the three months ended March 31, 2020.

Net interest income increased by $4.8 million, or 25.5 percent, to $23.6 million for the three months ended March 31, 2021 from $18.8 million for the three months ended March 31, 2020. The increase in net interest income resulted primarily from a $6.1 million decrease in interest expense related to a decrease in the average rate on interest-bearing liabilities of 93 basis points to 0.85 percent for the three months ended March 31, 2021 from 1.78 percent for the three months ended March 31, 2020, as well as a decrease in the average balance of interest-bearing liabilities of $273.5 million, or 11.4 percent, to $2.120 billion for the three months ended March 31, 2021 from $2.393 billion for the three months ended March 31, 2020. Interest income was $1.3 million lower than the prior year, related to a decrease in the average balance of interest-earning assets of $153.7 million, or 5.4 percent, to $2.705 billion for the three months ended March 31, 2021 from $2.859 billion for the three months ended March 31, 2020. The decrease in the average balance of interest-earning assets was partly offset by an increase in the average yield of interest-earning assets of three basis points to 4.15 percent for the three months ended March 31, 2021 from 4.12 percent for the three months ended March 31, 2020. The decrease in the average balance of interest earning assets mainly relates to a decrease in the Company’s level of cash balances for the three months ended March 31, 2021 as compared to the three months ended March 31, 2020, as the Company repaid $130.0 million of FHLB advances and purchased $70.0 million of BOLI.

Interest income on loans receivable increased by $49,000, or 0.2 percent, to $26.9 million for the three months ended March 31, 2021 from $26.8 million for the three months ended March 31, 2020. The increase was primarily attributable to an increase in the average balance of loans receivable of 140.5 million, or 6.4 percent, to $2.326 billion for the three months ended March 31, 2021. as compared to $2.186 billion for the three months ended March 31, 2020. The increase in interest income on loans receivable was partly offset by a decrease in the average yield of loans receivable of 29 basis points to 4.62 percent for the three months ended March 31, 2021 from 4.91 percent for the three months ended March 31, 2020. The increase in the average balance of loans receivable was attributable to the Company’s growth strategy. The decrease in the average yield on loans followed the declining interest rate environment. Interest income on loans also included $211,000 of amortization of purchase credit fair value adjustments for the three months ended March 31, 2021 related to the Company’s April 2018 acquisition of IA Bancorp, Inc. (“IAB”), which added approximately three basis points to the average yield on interest earning assets.

Interest income on securities increased by $419,000 or 73.4 percent, to $990,000 for the three months ended March 31, 2021 from $571,000 for the three months ended March 31, 2020. This increase was primarily due to an increase in the average balance of securities of $22.1 million, or 24.0 percent, to $114.5 million for the three months ended March 31, 2021 from $92.4 million for the three months ended March 31, 2020, as well as an increase in the average yield on securities of 99 basis points to 3.46 percent for the three months ended March 31, 2021 from 2.47 percent for the three months ended March 31, 2020. The increase in the average balance of securities resulted from purchases of new securities, partly offset by faster prepayment speeds, repayments, calls, and maturities, while the increase in the average yield on securities came as a result of the mix of purchases of new securities.

Interest income on other interest-earning assets decreased by $1.8 million, or 89.1 percent to $222,000 for the three months ended March 31, 2021 from $2.0 million for the three months ended March 31, 2020. This decrease was primarily due to a decrease in the average yield on other interest-earning assets of 106 basis points to 0.34 percent for the three months ended March 31, 2021 from 1.40 percent for the three months ended March 31, 2020, as well as a decrease in the average balance of other interest earning assets of $316.3 million, or 54.5 percent, to $264.3 million for the three months ended March 31, 2021 from $580.6 million for the three months ended March 31, 2020. The decrease in the average yield on other interest-earning assets correlated to the decreases in the Fed Funds rate. The decrease in the average balance of other interest-earning assets related to the Company’s current deleveraging strategy and the resulting decrease in cash attributable to loan growth, the purchase of BOLI and the early repayment of certain FHLB borrowings.

Total interest expense decreased by $6.1 million, or 57.6 percent, to $4.5 million for the three months ended March 31, 2021 from $10.6 million for the three months ended March 31, 2020. This decrease resulted primarily from a decrease in the average rate on interest-bearing liabilities of 93 basis points to 0.85 percent for the three months ended March 31, 2021 from 1.78 percent for the three months ended March 31, 2020, as well as a decrease in the average balance of interest-bearing liabilities of $273.5 million, or 11.4 percent, to $2.120 billion for the three months ended March 31, 2021 from $2.393 billion for the three months ended March 31, 2020. The decreases in the average cost of funds and the average balance of interest-bearing liabilities primarily resulted from the declining interest rate environment and the Company’s strategy of a heightened focus on cost of funds and continued deleveraging.

Total deposit interest expense decreased by $5.4 million, or 62.2 percent, to $3.3 million for the three months ended March 31, 2021 from $8.7 million for the three months ended March 31, 2020. This decrease resulted primarily from a decrease in the average rate on deposits of 97 basis points to 0.69 percent for the three months ended March 31, 2021 from 1.66 percent for the three months ended March 31, 2020, as well as a decrease in the average balance of deposits of 194.6 million, or 9.2 percent, to $1.914 billion for the three months ended March 31, 2021 from $2.108 billion for the three months ended March 31, 2020. The decrease in the average rate paid on deposits was primarily due to repricing our deposit base to align with the recent Fed rate reductions and aggressively managing the cost of funds. Approximately $255.4 million of certificates of deposit, with a weighted average rate of 1.37%, will mature in the next six months and is projected to be replaced at significantly lower rates.

Total borrowing interest expense decreased by $691,000, or 36.4 percent, to $1.2 million for the three months ended March 31, 2021 from $1.9 million for the three months ended March 31, 2020. The average balance of borrowings decreased by $78.9 million, or 27.7 percent, to $206.0 million for the three months ended March 31, 2021 from $284.9 million for the three months ended March 31, 2020, as well as a decrease in the average rate on borrowings of 32 basis points to 2.34 percent for the three months ended March 31, 2021 from 2.66 percent for the three months ended March 31, 2020. During the three months ended March 31, 2021, the Company opted to extinguish a $53.0 million FHLB advances which held a weighted average rate of 1.83% and were originally set to mature in 2021 and 2022. The extinguishment of this debt decreased both the average balance of borrowings and the average rate on borrowings for the three months ended March 31, 2021. The effect of the extinguishment of the debt reduced the weighted average cost of FHLB borrowings by approximately 20 basis points on an annualized basis. The related non-recurring expense for the extinguishment of this debt is included in noninterest expense.

Net interest margin was 3.48 percent for the first quarter of 2021, compared to 2.63 percent for the first quarter of 2020. Management has been proactive in managing its cost of funds and has significantly decreased the average cost on total interest-costing liabilities while slightly improving the average yield on interest-earning for the first quarter of 2021 compared to the first quarter of 2020. Despite the ongoing pandemic, the Company was been able to increase its average balance of loans receivable for the three months ended March 31, 2021 as compared to the three months ended March 31, 2020. This increase in the average balance of loans receivable, and the corresponding decrease in cash balances highlight management’s efforts to maintain a strong net interest margin.

The provision for loan losses increased by $365,000, to $1.9 million for the three months ended March 31, 2021 from a provision of $1.5 million for the three months ended March 31, 2020, primarily due to COVID-19 related factors. The provision for loan losses is established based upon management’s review of the Company’s loans and consideration of a variety of factors, including but not limited to: (1) the risk characteristics of the loan portfolio; (2) current economic conditions; (3) actual losses previously experienced; (4) the dynamic activity and fluctuating balance of loans receivable; and (5) the existing level of reserves for loan losses that are probable and estimable. The higher provision for loan losses for the three months ended March 31, 2021 was significantly influenced by the impact of COVID-19 on economic

27

conditions and the increased risk of loan defaults. During the three months ended March 31, 2021, the Company experienced $27,000 in net charge-offs compared to $300,000 in net recoveries for the three months ended March 31, 2020. The Bank had non-accrual loans totaling $14.4 million, or 0.62 percent, of gross loans at March 31, 2021 as compared to $4.4 million, or 0.20 percent, of gross loans at March 31, 2020. The allowance for loan losses was $35.5 million, or 1.52 percent of gross loans at March 31, 2021, and $25.5 million, or 1.17 percent of gross loans at March 31, 2020. The amount of the allowance is based on estimates and the ultimate losses may vary from such estimates. Management assesses the allowance for loan losses on a quarterly basis and makes provisions for loan losses as necessary in order to maintain the adequacy of the allowance. While management uses available information to recognize losses on loans, future loan loss provisions may be necessary based on changes in the aforementioned criteria. In addition, various regulatory agencies, as an integral part of their examination process, periodically review the allowance for loan losses and may require the Company to recognize additional provisions based on their judgment of information available to them at the time of their examination. Management believes that the allowance for loan losses was adequate at March 31, 2021 and March 31, 2020.

Total noninterest income increased by $1.3 million, or 185.5 percent, to $2.0 million for the three months ended March 31, 2021 from $683,000 for the three months ended March 31, 2020. The increase in total noninterest income was mainly related to higher BOLI income of $701,000, higher fees and service charges of $385,000, a lower unrealized loss on equity securities of $244,000, and a higher gain on the sales of loans of $213,000, partly offset by lower other noninterest income of $276,000. The increase in BOLI income relates to an initial purchase of $60.0 million of BOLI product in the third quarter of 2020, and an additional purchase of $8.5 million in the first quarter of 2021. The higher fees and service charges related primarily to $328,000 of referral fees for PPP loans. The decrease in other noninterest income related to the reversal of $295,000 of liabilities previously recorded for IAB acquired loans that paid off in the prior-year quarter The unrealized gains or losses on equity securities, and the decision to sell securities, are based on market conditions.

Total noninterest expense decreased by $781,000, or 5.4 percent, to $13.6 million for the three months ended March 31, 2021 from $14.4 million for the three months ended March 31, 2020.

Salaries and employee benefits expense decreased by $844,000, or 11.4 percent, to $6.5 million for the three months ended March 31, 2021 from $7.4 million for the three months ended March 31, 2020, primarily related to fewer full-time equivalent employees, partly offset by normal compensation increases. The number of full-time equivalent employees for the three months ended March 31, 2021 was 312, as compared with 371 for the same period in 2020.

Occupancy and equipment expense increased by $129,000, or 4.6 percent, to $3.0 million for the three months ended March 31, 2021 from $2.8 million for the three months ended March 31, 2020, largely related to building sanitization costs associated with the COVID-19 pandemic, partly offset by the closure of two of the Company’s branch offices in the fourth quarter of 2020.

Data processing expense increased $70,000, or 7.5 percent, to $1.0 million for the three months ended March 31, 2021 from $938,000 for the three months ended March 31, 2020, primarily related to upgrades to our core system.

Regulatory assessments increased by $55,000 to $376,000 for the three months ended March 31, 2021 from $321,000 for the three months ended March 31, 2020. The increase was primarily related to increases in the FDIC assessment rate and in the FDIC assessment base.

The Company recognized a non-recurring expense of $540,000 for a loss on extinguishment of debt, related to the prepayment of high-cost FHLB borrowings, for the three months ended March 31, 2021.

Other noninterest expense decreased by $491,000, or 24.8 percent, to $1.5 million for the three months ended March 31, 2021 from $2.0 million for the three months ended March 31, 2020. Other noninterest expense consisted of loan expense, business development, office supplies, correspondent bank fees, telephone and communication and miscellaneous fees and expenses. The decrease in the current period was primarily related to a reduction of business development and loan-related expenses, largely attributable to the current pandemic condition.

There were also less significant variances in professional fee expense, advertising expense, other real estate owned expense, and directors’ fees, which netted to a decrease in expenses of $240,000 for the three months ended March 31, 2021, as compared to the three months ended March 31, 2020.

The income tax provision increased by $1.9 million, or 173.9 percent, to $2.9 million for the three months ended March 31, 2021 from $1.0 million for the three months ended March 31, 2020. The increase in the income tax provision was a result of higher taxable income for the three months ended March 31, 2021 as compared with that same period for 2020. The consolidated effective tax rate for the three months ended March 31, 2021 was 29.3 percent compared to 29.9 percent for the three months ended March 31, 2020. The lower rate in the current period related primarily to non-taxable BOLI income and lower non-deductible costs in the current year period.

‎

28

Liquidity and Capital Resources

Liquidity

The overall objective of our liquidity management practices is to ensure the availability of sufficient funds to meet financial commitments and to take advantage of lending and investment opportunities. The Company manages liquidity in order to meet deposit withdrawals on demand or at contractual maturity, to repay borrowings and other obligations as they mature, and to fund loan and investment portfolio opportunities as they arise.

The Company’s primary sources of funds to satisfy its objectives are net growth in deposits (primarily retail), principal and interest payments on loans and investment securities, proceeds from the sale of originated loans and FHLB and other borrowings. The scheduled amortization of loans is a predictable source of funds. Deposit flows and mortgage prepayments are greatly influenced by general interest rates, economic conditions and competition. The Company has other sources of liquidity if a need for additional funds arises, including unsecured overnight lines of credit and other collateralized borrowings from the FHLB and other correspondent banks.

At March 31, 2021 and December 31, 2020, the Company had no overnight borrowings outstanding with the FHLB. The Company utilizes overnight borrowings from time to time to fund short-term liquidity needs. The Company had total FHLB borrowings of $133.3 million at March 31, 2021 and $191.2 million at December 31, 2020. The average rate of FHLB advances was 1.38 percent at March 31, 2021 and 1.66 percent at December 31, 2020. The subordinated debentures have a ten-year term and bear interest at a fixed annual rate of 5.625% for the first five years of the term. From and including August 1, 2023, the interest rate will adjust to a floating rate based on the LIBOR plus 2.72% until redemption or maturity. The Notes are scheduled to mature on August 1, 2028.

As it is anticipated that LIBOR will be discontinued after 2021, the Company is reviewing the agreements for the above debentures to determine alternative reference rates and does not anticipate there will be a significant financial statement impact.

The Company had the ability at March 31, 2021 to obtain additional funding from the FHLB of up to $245.7 million, utilizing unencumbered loan collateral. The Company expects to have sufficient funds available to meet current loan commitments in the normal course of business through typical sources of liquidity. Time deposits scheduled to mature in one year or less totaled $586.0 million at March 31, 2021. Based upon historical experience, management estimates that a significant portion of such deposits will remain with the Company.

The Company was well positioned with adequate levels of cash and liquid assets as of March 31, 2021, as well as wholesale borrowing capacity of over $800 million, to cover the decrease in cash flow resulting from COVID-19 loan deferments.

Capital Resources

The Bank is subject to various regulatory capital requirements administered by the federal banking agencies. Failure to meet the minimum capital requirements can initiate certain mandatory and possibly additional discretionary actions by regulators that, if undertaken, could have a direct material effect on the Company’s consolidated financial statements. Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Bank must meet specific capital guidelines that involve quantitative measures of the Bank’s assets, liabilities and certain off-balance sheet items as calculated under regulatory accounting practices. The Bank’s capital amounts and classification are also subject to qualitative judgments by the regulators about components, risk-weightings and other factors.

On September 17, 2019, the FDIC passed a final rule providing qualifying community banking organizations the ability to opt-in to a new community bank leverage ratio (tier 1 capital to average consolidated assets) (“CBLR”) framework, with a minimum requirement of 9% for institutions under $10 billion in assets. Such institutions meeting that requirement may elect to utilize the CBLR in lieu of the general applicable risk-based capital requirements under Basel III. Such institutions that meet the CBLR and certain other qualifying criteria will automatically be deemed to be well-capitalized. The Bank decided to opt-in to the new CBLR, effective for the quarter ended March 31, 2020. Pursuant to the CARES Act, the federal banking regulators in April 2020 issued interim final rules to set the CBLR at 8.0% beginning in the second quarter of 2020 through the end of 2020. Beginning in 2021, the CBLR increased to 8.5% for the calendar year. Community banks will have until January 1, 2022 before the CBLR requirement will return to 9%.

At March 31, 2021 and December 31, 2020, BCB Community Bank exceeded all of its regulatory capital requirements to which it was subject. The following table sets forth the regulatory capital ratios for BCB Community Bank as well as regulatory capital requirements for the periods presented.

|  | Actual |  |  |  | For Capital Adequacy Purposes |  |  |  | For Well Capitalized Under Prompt Corrective Action
| Dollars in Thousands
As of March 31, 2021: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Bank |  |  |  |  |  |  |  |  |  |  |  |  |  |
Community Bank Leverage Ratio | $ | 282,348 | 10.07 | % |  | $ | 196,268 | 7.00 | % |  |  | 238,326 | 8.50 | %
As of December 31, 2020: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Bank |  |  |  |  |  |  |  |  |  |  |  |  |  |
Community Bank Leverage Ratio | $ | 278,229 | 9.85 | % |  | $ | 197,169 | 7.00 | % |  | $ | 225,336 | 8.00 | %

The Company will continue to monitor the effects of COVID-19 in determining future cash dividends and any requirement for additional capital each quarter. The Company had $412,000 of stock repurchases for the first quarter of 2021.

‎

29

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Management of Market Risk

General. The majority of our assets and liabilities are monetary in nature. Consequently, one of our most significant forms of market risk is interest rate risk. Our assets, consisting primarily of mortgage loans, have longer maturities than our liabilities, consisting primarily of deposits. As a result, a principal part of our business strategy is to manage interest rate risk and reduce the exposure of our net interest income to changes in market interest rates. Accordingly, our Board of Directors has established an Asset/Liability Committee which is responsible for evaluating the interest rate risk inherent in our assets and liabilities, for determining the level of risk that is appropriate given our business strategy, operating environment, capital, liquidity and performance objectives, and for managing this risk consistent with the guidelines approved by the Board of Directors. Senior management monitors the level of interest rate risk on a regular basis and the Asset/Liability Committee, which consists of senior management and outside directors operating under a policy adopted by the Board of Directors, meets quarterly to review our asset/liability policies and interest rate risk position.

The following table presents the Company’s net portfolio value (“NPV”). These calculations were based upon assumptions believed to be fundamentally sound, although they may vary from assumptions utilized by other financial institutions. The information set forth below is based on data that included all financial instruments as of March 31, 2021. Assumptions have been made by the Company relating to interest rates, loan prepayment rates, core deposit duration, and the market values of certain assets and liabilities under the various interest rate scenarios. Actual maturity dates were used for fixed rate loans and certificate accounts. Investment securities were scheduled at either the maturity date or the next scheduled call date based upon management’s judgment of whether the particular security would be called in the current interest rate environment and under assumed interest rate scenarios. Variable rate loans were scheduled as of their next scheduled interest rate repricing date. Additional assumptions made in the preparation of the NPV table include prepayment rates on loans and mortgage-backed securities, core deposits without stated maturity dates were scheduled with an assumed term of 48 months, and money market and non-interest bearing accounts were scheduled with an assumed term of 24 months. The NPV at “PAR” represents the difference between the Company’s estimated value of assets and estimated value of liabilities assuming no change in interest rates. The NPV for a decrease of 200 to 300 basis points has been excluded since it would not be meaningful in the interest rate environment as of March 31, 2021.

The following table sets forth the Company’s NPV as of that date (dollars in thousands).

|  |  |  |  |  |  |  |  |  |  | NPV as a % of Assets |
Change in Calculation |  | Net Portfolio Value |  | $ Change from PAR |  | % Change from PAR |  | NPV Ratio |  | Change
+300bp |  | $ | 215,473 |  | $ | (22,573) |  | (9.48) | % |  | 8.00 | % |  | (37) | bp
+200bp |  |  | 227,964 |  |  | (10,082) |  | (4.24) |  |  | 8.30 |  |  | (7) | bp
+100bp |  |  | 238,564 |  |  | 518 |  | 0.22 |  |  | 8.53 |  |  | 16 | bp
PAR |  |  | 238,046 |  |  | - |  | - |  |  | 8.37 |  |  | - | bp
-100bp |  |  | 290,021 |  |  | 51,974 |  | 21.83 |  |  | 9.93 |  |  | 156 | bp

bp – basis points

The table above indicates that as of March 31, 2021, in the event of a 100 basis point increase in interest rates, we would experience an increase to 8.53% in NPV.

Certain shortcomings are inherent in the methodology used in the above interest rate risk measurement. Modeling changes in NPV require making certain assumptions that may or may not reflect the manner in which actual yields and costs respond to changes in market interest rates. In this regard, the NPV table presented assumes that the composition of our interest-sensitive assets and liabilities existing at the beginning of a period remains constant over the period being measured and assumes that a particular change in interest rates is reflected uniformly across the yield curve regardless of the duration or repricing of specific assets and liabilities. Accordingly, although the NPV table provides an indication of our interest rate risk exposure at a particular point in time, such measurements are not intended to and do not provide a precise forecast of the effect of changes in market interest rates on our net interest income, and will differ from actual results.

ITEM 4.

Controls and Procedures

Under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and Chief Financial Officer, the Company has evaluated the effectiveness of the design and operation of its disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this quarterly report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this quarterly report, the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed in the reports that the Company files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms.

There has been no change in the Company’s internal control over financial reporting during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORM ATION

ITEM 1. LEGAL PROCEEDINGS

We are involved, from time to time, as plaintiff or defendant in various legal actions arising in the normal course of business. As of March 31, 2021, we were not involved in any material legal proceedings the outcome of which, if determined in a manner adverse to the Company, would have a material adverse effect on our financial condition or results of operations.

‎

30

ITEM 1.A. RISK FA CTORS

None.

ITEM 2. UNREGISTER ED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On December 11, 2020, the Company issued a press release announcing the adoption of a new stock repurchase program, effective December 16, 2020. Under the stock repurchase program, management is authorized to repurchase up to 500,000 shares of the Company’s common stock.

The following table provides certain information related to shares repurchased by the Company during the three months ended March 31, 2021:

Period | Total Number of Shares Purchased |  |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs |  | Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
January 1 - January 31, 2021 | - |  | $ | - |  | - |  | -
February 1 - February 29, 2021 | - |  |  | - |  | - |  | -
March 1 - March 31, 2021 | 32,093 |  |  | 12.79 |  | 32,093 |  | 467,907
Total | 32,093 |  | $ | 12.79 |  | 32,093 |  | 467,907

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4. MINE SAFTEY DISCLOSURES

Not applicable

I TEM 5. OTHER INFORMATION

None.

‎

31

ITEM 6. EXHIBITS

Exhibit 31.1 | Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 31.2 | Certification of Principal Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 32 | Officers’ Certification filed pursuant to section 906 of the Sarbanes-Oxley Act of 2002.
Exhibit 101.INS | XBRL Instance Document
Exhibit 101.SCH | XBRL Taxonomy Extension Schema
Exhibit 101.CAL | XBRL Taxonomy Extension Calculation LinkBase
Exhibit 101.DEF | XBRL Taxonomy Extension Definition LinkBase
Exhibit 101.LAB | XBRL Taxonomy Extension Label LinkBase
Exhibit 101.PRE | XBRL Taxonomy Extension Presentation LinkBase

‎

32

Signatures

Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

|  | BCB BANCORP, INC.
Date: May 5, 2021 |  | By: |  | /s/ Thomas Coughlin
|  |  |  | Thomas Coughlin
|  |  |  | President and Chief Executive Officer (Principal Executive Officer)
Date: May 5, 2021 |  | By: |  | /s/ Thomas P. Keating
|  |  |  | Thomas P. Keating Senior Vice President and Chief Financial Officer
|  |  |  | (Principal Accounting and Financial Officer)

33